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ABSTRACT 
 
The health burden of human immunodeficiency virus (HIV) has improved with the introduction of 
antiretroviral therapy (ART). Near perfect adherence to ART is needed to ensure the maximum 
benefits of the drugs. Adherence is compromised by side effects and adverse drug reactions (ADRs) 
which may, in part, be due to drug induced oxidative stress. Rooibos (Aspalathus linearis) is a shrub-
like bush native to South Africa and is cultivated primarily as an herbal tea. Rooibos contains various 
polyphenols that add to its overall antioxidant capabilities. Aspalathin, the most abundant polyphenol 
present in rooibos, has shown potent antioxidant capabilities in vitro, providing an attractive model 
for therapy. The following study questions whether the histological observable effects of ART can 
be attenuated with the introduction of rooibos tea in vivo. The study aimed to assess the effects of 
combination ART, and rooibos tea on the histology of the pancreas, liver, and kidney in a HIV-
negative rat model. 
 
Rats (n=40) were subcatogorised into four groups namely: control (C), control ART (C-ART), control 
rooibos (C-R), and experimental (ART+R) groups. The C-ART and ART+R groups were 
administered a dose of combination ART consisting of 200 mg Emtricitabine (EMT), 600 mg 
Efavirenz (FTC) and 300 mg Tenofovir (TDF). A 2% (w/v) rooibos tea solution was administered ad 
libitum to C+R and ART+R groups. Samples of rooibos tea were analysed using liquid 
chromatography-mass spectrometry techniques to determine whether rats received the same 
concentrations of polyphenols throughout the investigation. Samples from the pancreas, liver, and 
kidney underwent standard histological processing. Routine haematoxylin and eosin stains and 
appropriate immunohistochemical and tinctorial techniques were conducted. Detailed morphometric 
measurements on pancreatic islet size, number and percentage of α and β-cells were performed. 
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were evaluated 
to test liver function. Changes in size of the glomerular corpuscle, glomeruli and proximal convoluted 
tubules (PCT) in the kidney were measured. Organ architecture, cellular structure and associated 
pathology were analysed in each organ, scored, and confirmed by a histopathologist.  
 
The size and number of pancreatic islets and the percentage of α and β-cells did not vary significantly 
from the control group. Serum AST and ALT levels did not vary significantly from controls indicating 
normal liver function. Glomerular corpuscle, glomeruli and PCT size remained constant compared to 
controls. No overt histopathology was present indicative of ART induced pancreatic toxicity, 
hepatotoxicity or nephrotoxicity. The results indicated no major changes between the various tea 
solutions indicating that the rats received similar concentrations of rooibos polyphenols throughout 
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the week. The study maintains that ART, when given to rats, does not cause significant changes to 
organ histomorphometry. While rooibos tea administration did not worsen, or improve organ 
histomorphometry. 
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OPSOMMING 
 
Die bekendstelling van antiretrovirale terapie (ART), het die gesondheidslas van die menslike 
immuniteitsgebreksvirus (MIV) verbeter. Om optimale voordeel uit die terapie te verkry, moet ART 
nakoming optimaal gehandhaaf word. Nakoming word egter belemmer deur newe-effekte en 
ongunstige geneesmiddelreaksies, wat gedeeltlik aan geneesmiddel geïnduseerde oksidatiewe stress 
toegeskryf kan word. Rooibos (Aspalathus linearis) is ‘n struikagtige gewas wat inheems aan Suid 
Afrika is en word hoofsaaklik as ‘n kruietee gekweek. Rooibos bevat verskeie polifenole wat tot die 
algehele antioksidatiewe effek van die tee bydra. Aspalathin, die hoof polifenol wat in rooibos 
teenwoordig is, het sterk antioksidantiewe eienskappe wat in vitro waargeneem is, en wat dit dus ‘n 
aanloklike model vir terapie maak. Die studie poog om te bepaal of die waarneembare histologiese 
effekte wat deur ART veroorsaak word, met die toediening van rooibostee in vivo verminder kan 
word. Die doel van hierdie studie was om die effek van ‘n kombinasie van ART en rooibostee op die 
histologie van die pankreas, lewer, en nier in ‘n MIV-negatiewe rotmodel waar te neem. 
 
Rotte (n=40) was in vier groepe verdeel, naamlik ‘n kontrole groep (K), kontrole ART groep (K-
ART), kontrole rooibos groep (K-R) en eksperimentele (ART+R) groep. Die K-ART en ART+R 
groepe het ‘n kombinasie ART middel ontvang, wat bestaan het uit 200 mg Emtricitabine (EMT), 
600 mg Efavirenz (FTC) en 300 mg Tenofovir (TDF) ingesluit het. ‘n Twee persent (w/v) rooibostee 
oplossing is ad libitum aan die K+R en ART+R groepe toegedien. Monsters van die rooibos tee was 
met behulp van ‘n vloeibare chromatografie-massaspektrometrie tegniek geanaliseer om te bepaal of 
die rotte dieselfde polifenol konsentrasie gedurende die eksperiment ontvang het. Monsters van die 
pankreas, lewer, en nier het standaard histologiese prosesering ondergaan, waartydens roetine 
Hematoksilien en Eosin-kleuring in kombinasie met toepaslike immunohistochemiese -en spesiale 
kleuring gedoen is. Gedetailleerde morfometriese afmetings is van die eilandgroottes van die 
pankreas gedoen, en die aantal en persentasie van α-en β-selle, is bepaal. Om lewerfunksie te bepaal, 
is serum alanien aminotransferase (ALT) en aspartaat aminotransferase (AST) vlakke geëvalueer. 
Veranderinge in die grootte van die glomerulêreliggaampie, glomeruli en proksimale kronkelbuise 
(PKB) in die nier is gemeet. ‘n In-diepte analise van die orgaan argitektuur, sellulêre struktuur, en 
gepaardgaande patologie is in elke orgaan gedoen. Die analise is deur ‘n histopatoloog bevestig. 
 
Die grootte en aantal pankreaseilande en die persentasie van α en β-selle in die eksperimentele groep 
het nie aansienlik van die kontrole groep verskil nie. Serum AST en ALT vlakke wat aanduidend van 
normale lewerfunksie is, het nie beduidend verskil van die kontrole groep nie, wat aanduidend van 
normale lewerfunksie is. In vergelyking met die kontroles, het die grootte van die glomerulêre 
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liggaampie, glomeruli en PKB konstant gebly. Geen duidelike histopatologie was teenwoordig, wat 
ART geïnduseerde pankreas-toksisiteit, hepatotoksisiteit of nefrotoksisiteit kon aandui nie. Die 
resultate het geen groot veranderinge tussen die verskeie tee oplossings getoon nie, wat bevestig dat 
die rotte soortgelyke polifenol konsentrasies gedurende die week ontvang het. Die studie bevind dat 
wanneer ART aan rotte toegedien word, dit nie betekenisvolle veranderinge aan die orgaan 
histomorfometrie veroorsaak nie. Verder, toediening van rooibostee versleg of verbeter nie die 
orgaanhistomorfometrie nie. 
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Infectious diseases, such as human immunodeficiency virus (HIV), are a global concern (World 
Health Organisation, 2016). Morbidity and mortality rates in HIV-infected individuals have been 
successfully reduced with the introduction of antiretroviral therapy (ART) (Pallela et al., 1998; El-
Sadre et al., 2003). Adherence plays a critical role in ensuring the success of treatment (Carr, 2013). 
Success is defined by the reduction in the human immunodeficiency pathogen and associated co-
morbid effects (Meintjes et al., 2017). However, increasing reports of adverse drug reactions (ADRs) 
in individuals receiving ART, has reduced adherence, thereby compromising the efficacy of treatment 
(Carr, 2003; Meintjes et al., 2017). The introduction of combination therapy in a single tablet design 
has increased adherence, however, ADRs are still reported (DeJesus et al., 2009; Meintjes et al., 
2017). Although it is important to understand the drugs individually, emphasis should be placed on 
ADRs of combination therapy, due to its emerging success. Little is known on the histological effect 
of the ART combination of Efavirenz (EFV), Emtricitabine (FTC) and Tenofovir disoproxil fumarate 
(TDF).  
  
There is sufficient evidence demonstrating drug associated pathology due to oxidative stress in the 
pancreas, liver and kidney following various ARTs (Puoti et al., 2003; Carr, 2003; Rudorf & 
Krikorian, 2005; Schmid et al., 2007; Deavall et al., 2012; Soriano et al., 2012, Meinjtes et al., 2017). 
However, these changes are difficult to assess histologically due to the lack of tissue samples, as these 
effects are often observed in a clinical environment on patients with HIV. It is therefore important 
that these changes be studied in a HIV-negative rodent model, to assess the histological observable 
effects of ART at a tissue level. This is to ascertain whether ART is the sole cause of reported ADRs 
or is influenced by external variables. Thus, it is imperative to introduce alternative, safe and effective 
therapies that will improve adherence by preventing ADRs.  
 
There has been a notable interest on the health promoting benefits of “functional foods” that have 
both nutritional and added health benefits (Joubert et al., 2005). Rooibos (Aspalathus linearis) can 
be described as a functional food with known in vitro (Ku et al., 2014, Gelderblom et al., 2016) and 
in vivo (Marnewick et al., 2003; Ulicina et al., 2005; Ayeleso et al., 2014, Canda et al., 2014; Ku et 
al., 2014) antioxidant capabilities, which have been well assessed. Rooibos is a readily available, low 
tannin, non-caffeinated, and popular beverage in South Africa (Morton, 1983). Due to its impressive 
antioxidant capabilities, in vitro (Viliano et al., 2010; Adjuwon et al., 2013; Chen et al., 2013) rooibos 
tea has been posited as a therapy for the prevention or reversal of adverse reactions caused by 
oxidative stress. Therefore, it is necessary to describe the effects of ART and rooibos tea consumption 
on the histomorphology of the pancreas, liver, and kidney. It is hypothesised, that the administration 
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of rooibos tea to rats receiving combination antiretroviral therapy (cART), may reduce the effects of 
ADRs at a tissue level. 
 
This study makes use of histomorphometry and semi-quantitative analyses by considering organ 
architecture and associated pathology. This was conducted to describe the histological observable 
effects of cART and rooibos on various organs. Additionally, an assessment of the polyphenol content 
of a standardised rooibos tea solution is reported, with notes on the effects of different storage 
scenarios on the polyphenolic content. This study will add to the academic body of work regarding 
the histological effects of cART and rooibos in a rat model, potentially contributing to the wellbeing 
of HIV-positive individuals receiving cART. 
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It is estimated that more than 30 million individuals are globally affected by the human 
immunodeficiency virus (HIV) with South Africa at the epicentre of the epidemic (World Health 
Organisation., 2007). The advent of highly active antiretroviral therapy (HAART) has significantly 
reduced morbidity and mortality rates (Jao & Wyatt, 2010). Highly active antiretroviral treatment 
typically makes use of three or more antiretroviral drugs from one or more classes, in a single tablet 
design (Rudorf & Krikorian, 2005). This design is a convenient method of providing the benefits of 
multiple drugs in a single dose, taken daily (Meintjes et al., 2017). The Southern African HIV 
Clinicians Society guidelines (2017) state that the main goal of antiretroviral therapy (ART) is to 
provide maximum suppression of HIV, restore immune function, decrease the risk of co-opportunistic 
infections, increase life-expectancy, and prevent HIV transmission while minimising adverse drug 
reactions (ADRs) (Meintjes et al., 2017). Although these drugs are highly successful, reports on ART 
associated ADRs hinder the efficacy of treatment by compromising adherence (Brinkman et al., 1998; 
Carr & Cooper, 2000; Ammassari et al., 2001; Fellay et al., 2001; Carr, 2003; Rudorf & Krikorian, 
2005; Jao & Wyatt, 2010). 
 
There are various classes of ART including non-nucleoside reverse transcriptase inhibitors (NNRTI), 
nucleoside reverse transcriptase inhibitors (NRTI), protein inhibitors (PI), fusion inhibitors (FI) (Carr 
& Cooper, 2000), and entry inhibitors (EI) (US Food and Drug Administration, 2015). Adherence to 
these drugs is critical to maximise the long-term benefits, while minimising the risk of opportunistic 
infections and lowering infection rates (Monforte et al., 2001). 
 
Rudorf and Krikorian (2005) reviewed the short-and long-term effects of ARTs, and reported that 
severe adverse events were associated with long term exposure. These ADRs may be due to 
combination treatment or individual drug interactions  (Carr & Cooper, 2000). As a result, long term 
exposure has resulted in oxidative stress, compromising organ systems and cellular components 
(Brinkman et al., 1998; Rudorf & Krikorian, 2005). Although, clinical studies have been conducted 
on the efficacy of the ART in clinical settings, the long term and short term exposure has been under 
reported and poorly studied, specifically in HIV-negative animal models (Styrt et al., 1996; Saag, 
2007; Carr & Cooper, 2000; Jao & Wyatt, 2010).  
 
2.1 DEFINITIONS AND MECHANISM OF ACTION OF ANTIRETROVIRAL DRUGS  
Antiretroviral drugs are orally administered to treat the actions of retro-viruses, such as HIV (Carr & 
Cooper, 2010). Six classes of the drug have been approved by the United States Food and Drug 
administration (US FDA) (2015), however only the three most used classes in South Africa are 
described (Table 2.1). The following section will focus on the actions of the antiretroviral drugs, 
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Efavirenz (EFV), Emitricitabine (FTC) and Tenofovir (TDF), alone and in combination. These drugs 
are currently used in first line combination treatment, particularly, in South Africa (Meintjes et al., 
2017) and are prescribed in combination as either Odimune® or Atripla®. Odimune® is used in South 
Africa as a cost-effective alternative to monotherapy (Meintjes et al., 2017). It is imperative to study 
the adverse events of ARTs, as this could potentially lead to safer more effective long term treatment 
options (Carr, 2003). The scope of the research is limited to the ADRs in the pancreas, liver, and 
kidney. 
 
Table 2.1: Current antiretroviral drugs approved by the United States Food and Drug Administration. 
Dates indicate year of release (Adapted from: US Food and Drug Administration: FDA-Approved HIV 
Medicines, 2016). 
Nucleoside reverse 
transcriptase inhibitors 
(NRTIs) 
Non-nucleoside reverse transcriptase 
inhibitors (NNRTIs) 
Protease Inhibitors 
(PIs) 
Zidovudine, 1987 Nevirapine, 1996 Saquinavir, 1995 
Stavudine, 1994 Efavirenz, 1998* Indinavir, 1996 
Lamivudine, 1995 Etravirine, 2008 Ritonavir, 1996 
Abacavir, 1998 Rilpivirine, 2011 Fosamprenavir, 2003 
Didanosine, 2000  Atazanavir, 2003 
Tenofovir disoproxil fumarate, 2001* 
Emtricitabine, 2003* 
 Tipranavir, 2005 
Duranavir, 2006 
* Drugs used in combination in the current study.  
 
2.1.1 Efavirenz 
Efavirenz was first approved in 1998 by the US FDA for the treatment of HIV in combination with 
other antiretroviral agents for use in adults and children over three years of age (Staszewski, 2007). 
Chemically, the drug is described as (S)-6-chloro-4-(cylopropylethynyl1)-1, 4-dihydro-4-
(trifluoromethyl) – 2H-3, 1-benzoxazin-2-one (Atripla® product information, 2017) (Figure 2.1 A). 
The drug is a NNRTI, functioning as a non-competitive inhibitor of HIV reverse transcriptase (Figure 
2.2). The drug binds directly to the reverse transcriptase enzyme, causing the disruption of catalytic 
site. This inhibits the polymerase activity of HIV and reduces the formation of new viral 
deoxyribonucleic acid (DNA) (Young et al., 1995). 
 
In the liver, EFV is metabolised by hepatic cytochrome isoenzymes (Mutlib et al., 1998; Deeks & 
Perry, 2010), leading to glucorondination. Glucorondination refers to the process where drugs and 
other compound are mixed with glucuronic acid, forming water soluble compounds that are easily 
excreted by the kidneys. Efavirenz is primarily excreted in the faeces as a metabolite and in its original 
form (Atripla® product information, 2017). Efavirenz is recommended for combination therapy 
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regimes, as monotherapy could lead to the selection of highly drug resistant variants (Staszewski, 
2007). Due to the excellent bioavailability and potency, EFV is optimal for combination treatment 
(Young et al., 1995).  
 
 
Figure 2.1: The chemical structures of the antiretroviral drugs. A) Efavirenz C14H9ClF3NO2; B) 
Emitricitabine C8H10FN3O3S; and C) Tenofovir C19H30N5O10P Adapted from:(Atripla®, product information, 
2017). 
 
2.1.2 Emitricitabine  
First described by Schinazi and collegues in 1992, Emitricitabine (FTC) is a NRTI with antiviral 
activity against the actions of HIV, and in some cases, Hepatitis-B virus (HBV) (Schinazi et al., 
1992a). Emitricitabine only received approval for the treatment of HIV by the FDA in 2003 (US 
FDA, 2016). The drug is in the “preferred category” for combination treatments due to its safety and 
low toxicology effects (Mugavero & Wellons, 2008).  
 
Chemically, FTC is a negative or cis enantiomer of 2’, 3’-dideoxy-5-fluoro-3’-thiacytidine (Schinazi 
et al., 1992a; Van Roey et al., 1993) (Figure 2.1 B). Like other NRTIs, the drug must be metabolised 
to its active form by intra-cellular kinases (Paff et al., 1994). The drug inhibits the binding of HIV 
phosphatases to reverse transcriptase, limiting DNA synthesis of new HIV virions (Wilson et al., 
1993) (Figure 2.2). Emtricitabine is rapidly absorbed following oral administration and is mainly 
excreted by the kidneys (Deeks & Perry, 2010). Administration of a single dose of FTC (200 mg) 
demonstrated an 85% recovery in urine and 13% in faeces (Mugavero & Wellons, 2008; Deeks & 
Perry, 2010). Few adverse events were recorded in animal studies, placing FTC in the “preferred 
category” of ART (Schinazi et al., 1992b; Frick et al., 1993). 
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Figure 2.2: The human immunodeficiency virus life cycle and antiretroviral therapy drug targets. 
Illustration of the main steps in the HIV replication cycle showing recognition of the virion into the host CD4+ 
cell, fusion within the host membrane, uncoating of the capsid releasing viral RNA strands. Through reverse 
transcription viral RNA is transcribed to viral DNA which is then integrated into the host cell DNA. The host 
cell then undergoes normal replication of the new viral DNA, which is assembled and released. The image 
further shows the major targets of ART (green blocks) in the virus life cycle. Adapted from: (Barré-Sinoussi 
et al., 2013). 
 
2.1.3 Tenofovir  
Tenofovir disoproxil fumarate (TDF) is an oral drug with activity against HIV and hepatitis infections 
(Hoesley, 2008). Chemically, the structure of TDF is a 9-[(R)-(2-phosphonylmethoxy) propyl] 
adenine (Figure 1.2 C). The drug is a lipophilic ester that is designed to improve oral bioavailability 
(Naesens et al., 1997), which is enhanced by a high-fat meal (Kearney et al., 2004). The drug differs 
from other classic nucleoside analogues as it does not depend on intracellular enzymes for activation 
(Naesens et al., 1997). Tenofovir was approved by the US FDA in 2001 and was released for triple 
fixed dose combination treatment in 2006 (Hoesley, 2008). 
 
The drug interacts with viral DNA polymerases and reverse transcriptase, acting as both a competitive 
inhibitor and an alternative binding site for the DNA polymerase chain reaction, subsequently 
terminating HIV DNA replication (Naesens et al., 1997) (Figure 2.2). Due to the intracellular (≥60 
hours) and serum (17 hours) half-life, the drug provides an ideal model for flexible once-daily 
administration (Kearney et al., 2004). Tenofovir is primarily excreted in the kidneys, mediated by the 
action of glomerular filtration and secretions of the proximal convoluted tubules (PCT) (Ray et al., 
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2006). In vitro metabolic studies and animal studies have found that TDF is eliminated unchanged in 
urine 24 hours after the initial dose (Lebrecht et al., 2009). Tenofovir is a substrate for the organic 
anion transporters OAT-1 and OAT-3 in PCTs, it is hypothesised that these transporters are 
responsible for the drugs secretion in urine in its unchanged form (Ray et al., 2006). It is important 
to understand the drugs individually as Mathias et al (2007) concluded that TDF/FTC/EFV drugs in 
combination are equivalent to their individual actions. The emerging success of combination therapy 
has provided an opportunity for their research in various organ systems. 
 
2.2 ANTIRETROVIRAL TREATMENT AND ADVERSE DRUG REACTIONS 
Highly active antiretroviral treatment is the combination of two or more antiretroviral drugs that act 
synergistically to supress HIV replication (Deeks & Perry, 2010). Combination therapy is a first line 
treatment that drastically increases the life span of infected individuals (May et al., 2014). 
 
There are two main draw backs associated with combination treatment. Firstly, low compliance to 
medication and secondly, ADRs (Monforte et al., 1998; Monforte et al., 2001). Fellay and colleagues 
(2001) reported that out of 1160 patients receiving combination ART (cART), 74% presented with 
ADRs. Additionally, O’Brien et al (2003) found that at least 24% of 345 patients discontinued 
treatment as result of ADRs. Multiple organs, cells, and cellular organelles are affected by ART, 
possibly due to the type of drug, drug class, or the actions of HIV itself (Rudorf & Krikorian, 2005). 
A summary of the short and long term effects of ART is presented in Table 2.2.  
 
2.2.1 Pancreatic adverse drug reactions 
Metabolic changes (Lagathu et al., 2007; Stein et al., 2008; Lugassy et al., 2010), acute pancreatitis 
(Andersen et al., 2001) and an increased incidence of diabetes (Brown et al., 2005) have been reported 
with ART. A systematic review conducted by Oliveira et al (2014), summarised that EFV and TDF 
were risk factors for acute pancreatitis, however, these were secondary to hyperlipidaemia. Acute 
pancreatitis refers to the activation of pancreatic enzymes, such as amylase levels, leading to 
pancreatic damage (Kloppel & Maillet, 1993). Histologically, this is observed in the pancreatic acinar 
cells where necro-inflammatory changes occur, leading to oedema in severe cases (Kloppel & 
Maillet, 1993). Manfredi and Calza (2008) noted that patients using NRTIs in combination had an 
increased risk of pancreatic enzyme elevations, which were worsened by alcohol use, occurrence of 
co-infections or the combination of these factors. 
 
Post-mortem histological studies found no evidence of pancreatic lesions associated with the use of 
ART (Barbosa et al., 2013). However, a decrease in zymogen granules, and core dysplasia-like 
Stellenbosch University  https://scholar.sun.ac.za
10 
 
 
alterations were observed (Barbosa et al., 2013). The study concluded that these changes may be due 
to nutritional or HIV related factors (Barbosa et al., 2013). Additionally, Ferreira et al (2015) noted 
increased islet areas in ART-treated individuals compared to control groups. However, the same study 
found larger islets in HIV-infected individuals agreeing with observations conducted by Chehter et 
al (2000). This study further stated that pancreatic changes may have been due to nutritional or HIV 
related causes (Chehter et al., 2000). These studies (Chehter et al., 2000; Barbosa et al., 2013) further 
reiterate the gap of knowledge on the effects of combination ART on the histomorphometry of 
pancreatic islets in HIV-negative rodent models.  
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Table 2.2: Summary of the short-and long-term antiretroviral therapy associated adverse drug reactions (adapted from Rudorf & Krikorian, 2005). 
Protease inhibitor (PI); Nucleoside reverse transcriptase inhibitor (NRTI); Non-Nucleoside reverse transcriptase inhibitors (NNRTI); Efavirenz (EFV); Emtricitabine 
(FTC); Tenofovir (TDF); Didanosine (ddI); Stavudine (d4T); Nevirapine (NVP); Central Nervous system (CNS); Alanine aminotransferase (ALT); Aspartate 
aminotransferase (AST).
Adverse Reaction Drug or Drug Class Initiation After Therapy Comments 
Short Term  
Central nervous system EFV, FTC 2-4 weeks/ long term Exacerbated by existing CNS or psychiatric conditions and CNS drugs 
Gastrointestinal PIs, some NRTIs Early treatment Diarrhoea common, conditions exacerbated by pre-existing conditions 
Hyperpigmentation FTC First few months Noticed primarily in black individuals 
Skin irritations NRTIs  From onset  Severe reactions may lead to discontinuation 
Long Term  
Pancreatitis ddI, d4T Weeks to months Increased risk with history of disease, associated in combination with TDF 
Hepatoxicity serum PIs, NNRTIs, NRTIs Weeks to months Increased risk with co-infections, alcohol, or hepatotoxic drug use 
Hepatotoxicity necrosis Mostly NVP  First few weeks to 18 weeks Accompanied by ALT/AST elevation, coinfections, alcohol, or hepatotoxic 
drug use 
Nephrotoxicity TDF Weeks to months Increased risk with history of renal disease, decreased fluid intake, use of 
nephrotoxic drugs 
Hyperglycaemia/ 
hyperinsulinemia 
Mostly NVP  Weeks to months Increased risk with diabetes 
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2.2.2 Liver adverse drug reactions 
Liver toxicities have been reported to occur across all classes of ARTs (Carr, 2003). Efavirenz is 
linked to liver toxicities specifically in combination treatment (Pérez et al., 2009). Although, a study 
by Minzi et al (2009) noted that these toxicities were higher in nevirapine (NVP) treated patients 
compared to those prescribed EFV. Schouten et al (2010) found severe cases of liver pathology in 
only 4% of patients who substituted NVP with EFV; however, these changes were reversible.  
 
Liver toxicities present as liver enzyme elevations, specifically those of alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), bilirubin and alkaline phosphatases (Schouten et al., 2010). 
The study conducted by Wit et al (2002) noted that approximately 8% of patients receiving ART in 
combination had liver enzyme elevations 10 times above the average, with 35% of patients 
discontinuing treatment. While Wester et al (2010) reported that only 6.3% of the total population 
studied reported hepatotoxicity in the form of liver enzyme elevations.  
 
The exact mechanism of ART associated liver toxicity is poorly understood (Sulkowski 2004). This 
could be due to compounding factors and/or drug-drug interactions (Dieterich et al., 2004; Sulkowski, 
2004). However, the mechanisms of drug induced hepatotoxicity leading to histologically observable 
changes has been defined (Bissell et al., 2001; Bliebel et al., 2007). Figure 2.3 illustrates the various 
ways in which the liver may be damaged by drugs. Hepatotoxicity may present as necro-inflammatory 
changes similar to that observed in chronic viral hepatitis (Zimmerman, 1999). Additionally, 
distortion to liver architecture may occur (Neuman et al., 2012). Instances of necrosis and severe 
congestion of the portal and venous system have been reported with the use of ART (Adaramoye et 
al., 2012). Often, these changes may be exacerbated by the presence of co-opportunistic infections 
such as hepatitis (Núñez, 2006). 
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Figure 2.3: Demonstration of the cellular mechanism involved in drug induced liver toxicity leading to histological visible changes. Drug induced liver injures 
(DILI) may be immune mediated, non-immune mediated, directly toxic or dose dependant. Immune mediated changes activate immune responses leading to cellular 
destruction, inflammation, phagocytosis or apoptosis. Non-immune mediate injuries may be directly toxic to cellular organs, leading to intracellular stress and cellular 
dysfunction leading to necrosis or elevations of liver enzyme. Toxic events may be dose dependent leading to direct cellular injury however these are limited to specific 
drugs (Adapted from: Bleibel et al., 2007). 
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2.2.3 Kidney adverse drug reactions 
Numerous studies have reported renal toxicities associated with TDF (Kohler et al., 2009; Lebrecht 
et al., 2009; Herlitz et al., 2010). Tenofovir associated glomerular toxicity accounts for 20% of 
consultations to nephrologists (Hall, 2013), often resulting in damage to the PCTs or changes in 
glomerular filtration (Post et al., 2010; Fabien et al., 2013). However, glomerular filtration rate 
changes have been associated with the action of the PCTs and not to the actions of the glomerulus 
(Vrouenraets et al., 2011). Nephrotoxicity may depend on specific patient profiles, the type of drug, 
and regimen which the patient is prescribed (Kalyesubula & Perazella, 2011). Diabetes mellitus 
(DM), kidney disease and additional nephrotoxic agents are additional factors that may account for 
renal changes in HIV-infected patients receiving ART (Kalyesubula & Perazella, 2011). Table 2.3 
summarises adverse events associated with TDF use in the kidney. 
 
The persistence of ADRs and subsequent withdrawal from treatment suggests the need for therapeutic 
agents to attenuate these reactions. These adverse effects lead to additional medical expenses which 
is not sustainable in low socioeconomic countries. This further illustrates the need for affordable 
products that can attenuate ADRs (Núñez, 2006). Although, ADRs are numerous and compounded 
by opportunistic infections, these should not motivate withdrawal from treatment (Schmid et al., 
2007). Other factors, including oxidative stress may play a significant role on the incidence of ADRs 
in HIV-positive individuals. 
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Table 2.3: Summary of studies on tenofovir induced adverse drugs reactions. 
Study Drug or Drug 
Combination 
Subjects Duration Adverse Event Comments  
Gallent et al., 
2005 
TDF HIV-Positive Patients 
(n=344) 
Case 
Reports 
Increases in creatinine levels Increased creatinine elevations were not associated 
with co-infections 
      
Kohler et al., 
2009 
TDF 
100 mg/kg/day 
HIV-Transgenic Mice  
(n=20) 
5 Weeks No histological observable changes 
using light microscopy 
Electron microscopy showed increased 
mitochondria with irregular shape and fragmented 
cristae in PCTs 
      
Lebrecht et al., 
2009 
TDF or ddI 
100 mg/kg/day 
Male Sprague Dawley 
Rats (n=8) 
8 Weeks Increased diameter of PCTs with TDF Lower body and kidney weight with TDF, lipid 
droplets observed in PCTs 
      
Herlitz et al., 
2010 
TDF HIV-Positive Patients  
(n=13) 
19.6±26.1 
Months 
Degenerative changes to PCTs and 
acute tubular necrosis 
Nephrotoxicity was associated with intra-
cytoplasmic inclusions in the PCT epithelial cells 
      
Post et al.,  
2010 
ABC / 3TC / EFV 
vs 
TDF / FTC / EFV 
HIV-Positive Patients  
(n=385) 
96 Weeks Increased markers of tubular 
dysfunction in TDF/FTC/EFT 
No difference in glomerular filtration rate between 
regimens 
Abacavir (ABC); Lamivudine (3TC); Didanosine (ddI); Tenofovir (TDF); Efavirenz (EFV); Emtricitabine (FTC); Proximal convoluted tubule (PCT).
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2.3 OXIDATIVE STRESS, REACTIVE OXYGEN SPECIES AND ANTIRETROVIRAL 
THERAPY 
Oxidative stress is a natural product of cellular metabolism and is defined as the overproduction or 
insufficient removal of reactive oxygen species (ROS). Reactive oxygen species are in the form of 
superoxide, hydroxyl, peroxyl and hydroperoxyl radicals (D’Autréaux & Toledano, 2007), including 
the non-radicals, hydrogen peroxide, and hydrochloric acid (Figure 2.4).  
 
 
Figure 2.4: Types of reactive oxygen species and electron pairs (Adapted from: Deavall et al., 2012).  
 
Chemically, ROS can be described in terms of reduction and oxidation reactions (REDOX). Oxidants, 
are oxygen compounds that receive electrons, while reductants refer to oxygen compounds losing 
electrons. Therefore, oxidation is the loss of electrons, and reduction is the subsequent gain (Kohen 
& Nyska, 2002). Reductants and oxidants are chemical terms for antioxidant and pro-oxidants, 
respectively, and will hereon be referred to as such. 
 
A balance must be found between pro-oxidants and antioxidants for normal cellular function 
(Kuwabara et al., 2008). Reactive oxygen species are able to initiate and mediate normal 
physiological processes (Kuwabara et al., 2008). However, damage occurs when the accumulation of 
ROS exceeds cellular tolerance leading to oxidative stress (Kohen & Nyska, 2002). Long term 
exposure to oxidative stress leads to toxicity (Kohen & Nyska, 2002). An interest in the effects of 
oxidative stress has emerged in biomedical research due to the evidence that oxidative stress is a risk 
factor for the development of different diseases (Pitocco et al., 2013). This is exacerbated by external 
factors such as drugs, food, and ultra-violet radiation (Figure 2.5). The over production of ROS can 
be attenuated by the introduction of antioxidants.  
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Figure 2.5: Exogenous and endogenous sources leading to reactive oxygen species. Both exogenous and 
endogenous sources of ROS are listed. Drugs enter the cellular membrane for normal metabolism causing an 
increase in reactive oxygen molecules in mitochondria. The overaccumulation of ROS leads to lipid damage, 
protein damage, DNA damage or the activation of kinases. These processes may eventually lead to apoptosis. 
Adapted from (Kohen & Nyska, 2002; Deavall et al., 2012).Reactive oxygen species (ROS); Tumour protein 
(P53). 
 
Cellular mitochondria are directly associated with the production of ROS (Kohen & Nyska, 2002). 
The occurrence of oxidative stress has been implied with the use of ART due to the emergence of 
mitochondrial toxicities, which have been extensively reviewed (Brinkman et al., 1998; Carr & 
cooper, 2000; Carr, 2003). Long term exposure to ART is associated with morphological and 
ultrastructural changes to mitochondria (Kohler et al., 2009; Deavall et al., 2012). Two in vitro studies 
have directly associated the use of ART to increased ROS, resulting in mitochondrial dysfunction 
and oxidative stress (Jiang et al., 2007; Manda et al., 2011). These effects could potentially be 
mediated by introducing external sources of antioxidants such as rooibos. 
 
2.4 OVERVIEW OF ROOIBOS  
Rooibos or Aspalathus linearis (Burm.f.) Dahlgren, is native to the Cederberg mountains in the 
Western Cape region of South Africa (Morton, 1983). Rooibos (Fabacea, tribe: Crotalariae) is 
described as a shrub-like bush containing bright green, linear, sharp leaves with small clusters of 
yellow flowers resembling those found on pea plants (Figure 2.6) (Morton, 1983). There are two 
types of rooibos plants; the commonly cultivated “Nortier”-red type, and the wild “Cederberg” type 
(Morton, 1983; Joubert & de Beer, 2011).  
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Figure 2.6: Aspalathus linearis bush and the chemical structure of Aspalathin. Adapted from: (Bramati 
et al., 2002). 
 
The South African Rooibos Council (n.d.), reported that the first account of rooibos use was in 1772 
by the botanist and Dutch settler Carl Thunberg. Yet, it was only in 1904 that Benjamin Ginsberg 
first began the commercial sale and marketing of rooibos (Joubert & de Beer, 2011). The shortage of 
oriental black tea (Camillia sinensis) in the Second World War, and subsequent market collapse, 
spurred the production of alternative tea types resulting in the establishment of the Clanwilliam Tea 
Co-operative company in 1948 (Joubert & de Beer, 2011). However, in 1953 and 1954, rooibos 
became uneconomical due to market declines which lead to the founding of the Rooibos Tea Board 
in 1954 that aimed to establish a stable industry for rooibos (Joubert & de Beer, 2011). Now, the 
production, marketing and sustainable cultivation of rooibos falls under the South African Rooibos 
Council (SARC) (Joubert & de Beer, 2011). Currently over 14 000 tons of rooibos is produced in 
South Africa with approximately 6 000 tons being exported to international markets in Germany, 
United Kingdom and Japan (South African Rooibos Council, n.d.). 
 
Rooibos is recognised as a herbal tisane, although marketed as “tea”. The term “tea” is only 
recognised for leaves from Camillia senensis; however, this term is used interchangeably in literature 
(Mckay & Blumberg, 2007). Rooibos first gained popularity as a herbal, low tannin, caffeine-free 
beverage that contributes to the total daily water recommendations (Joubert & de Beer, 2011). 
However, this shifted when a mother, Anique Theron, provided anecdotal evidence stating that the 
tea could be used to treat colic in infants (Morton, 1983). Now, rooibos popularity had increased due 
to its postulated antioxidant potential (Marnewick et al., 2000).  
 
Rooibos contains a unique array of polyphenols that contribute to the overall antioxidant capacity of 
the tea. The tea is the only known source of the C-C linked dihydrochalcone, aspalathin (Figure 2.6), 
and one of only two known sources of nothofagin ( Standley et al., 2001; Mckay & Blumberg, 2007). 
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The processing style of the tea is known to affect the chemical composition of the tea (Mckay & 
Blumberg, 2007). 
 
2.4.1 Composition of rooibos 
Rooibos contains approximately 25 major polyphenols (Iswaldi et al., 2011) of which the 15 principle 
polyphenols are listed in Table 2.4. These are grouped as dihydrochalcones, flavones, flavanols, 
phenylpropanoid and hydroxycinnamic acid (Joubert et al., 2008; Beelders et al., 2012).  
 
Table 2.4: Main polyphenols found in rooibos adapted from (Beelders et al., 2012). 
Group Phenolic compound 
Dihydrochalcones Aspalathin, Nothofagin 
Flavones Orientin, Iso-orientin, Vitexin, Iso-vitexin, Luteolin, Luteolin-7-O-glucoside, 
Chrysoeriol 
Flavanols Quercetin, Iso-quercetin, Hyperoside, Rutin 
Phenylpropanoid Phenylpyruvic acid-2-o-glucoside 
Hydroxycinnammic acid Ferulic acid 
 
Rooibos cultivators still employ the traditional methods of fermentation by sun drying, browning, 
and bruising of leaves and stems to achieve the familiar red-brown colour of the tea (Joubert & de 
Beer, 2011). The fermentation process causes a significant loss in the polyphenol composition of the 
tea, specifically, the main antioxidant, aspalathin (Koeppen & Roux, 1966; Joubert, 1996a; Canda et 
al., 2014). During fermentation, aspalathin is replaced, due to degradation, with the high molecular 
weight compounds iso-orientin and orientin (Krafczyk & Glomb, 2008), allowing for the rich red 
colour associated with the tea (Krafczyk et al., 2009). To reduce the loss of polyphenols during 
fermentation, the Agricultural Research Council (ARC) proposed a new processing method that 
contained higher concentrations of the polyphenols specifically aspalathin (Joubert & de Beer, 2011). 
Although, both the fermented and unfermented versions are commercially available the fermented 
version still remains the most commonly consumed of the two (Beelders et al., 2012). 
 
Fermented rooibos is appealing due to its taste; however, from a therapeutic stance, the loss of its 
antioxidant capability is concerning, since fermented samples contain less the 10% of the original 
phenolic content (Table 2.5) (Joubert, 1996b, Muller et al., 2016). This loss is problematic as 
aspalathin, followed by quercetin, and nothofagin (Snijman et al., 2007), have shown impressive 
antioxidant capabilities (Yoshikawa et al., 1990; Snijman et al., 2009; Villaño et al., 2010). This 
makes rooibos an attractive therapeutic agent to attenuate the effects of oxidative stress (von Gadow 
et al., 1996; Marnewick et al., 2004; Krafczyk et al., 2009). 
 
Stellenbosch University  https://scholar.sun.ac.za
20 
 
 
Table 2.5: Polyphenol changes and total antioxidant capacity between fermented and unfermented 
samples of rooibos (Marnewick, 2014). 
Rooibos type Total polyphenol content 
(mg GAE) b 
Total flavones/flavanols  
(mg quercetin equivalents) c 
Total antioxidant 
capacityd 
Fermented * 73.43±1.79 33.44±0.38 1537.60± 27.40 
Unfermented  106.46±2.14 26.85±0.28 2093.57±50.20 
a Fermented rooibos based on one cup = 200 mL prepared by steeping one rooibos tea bag in 200 mL fresh 
boiled water. b Folin-Ciocalteu methods measured against gaelic acid equivalents(GAE).c 360 nano method.  
d Based on the oxygen radical absorbance capacity (± Std. Dev) of ten samples. 
 
In order to preserve rooibos polyphenols, Joubert and de Beer (2011) patented a new vacuum drying 
technique; however, the high costs of the method hinders its commercialisation. By limiting the 
exposure of rooibos leaves and stems to oxygen, direct sunlight (Koeppen & Roux, 1966), pH 
fluctuations, and low temperatures, the preservation of the aspalathin and other phenolic compounds 
may be limited (Joubert & de Beer, 2011).The demand for investigations on the therapeutic actions 
of rooibos stresses the need for quantitative and qualitative polyphenol amounts to be reported in the 
literature. This allows for researchers to make convincing conclusions on the putative therapeutic 
actions of rooibos.  
 
2.4.2 Protective effects of rooibos 
Studies have shown the anti-inflammatory activity (Baba et al., 2009, Hendricks & Pool, 2010; 
Schloms et al., 2012), chemo-protective (Marnewick et al., 2009 Joubert & de Beer, 2011), 
antimutagenic (Snjiman et al., 2007; Canda et al., 2014; Gelderblom et al., 2016), anti-carcinogenic 
(Petrova, 2009), antidiabetic (Ulcina et al., 2006; Francisco, 2010; Muller et al., 2012, Mazibuko et 
al., 2013; Kamakura et al., 2015), anti-obesity (Beltran-Debon et al., 2011, Son et al., 2013; 
Sanderson et al., 2014), and antioxidant effects (Bramati et al., 2003; Awoniyi et al., 2012; Chen et 
al., 2013) of rooibos. Table 2.6 summarises some of the in vitro studies conducted. 
 
One of the first rat studies conducted on rooibos showed reduced lipid peroxidation in the brain of 
aged female Wistar rats (Inanami et al., 1995), concluding that the flavonoids found in rooibos acted 
as free radical scavengers (Inanami et al., 1995). Pantsi et al (2011) showed the cardiac protective 
capabilities in male Wistar rats exposed to both fermented and unfermented rooibos. The study 
observed that rooibos extracts significantly improved aortic output with no effect on the REDOX 
status (Pantsi et al., 2011). The authors further postulated, that protection exhibited by rooibos may 
be due to the inhibition of apoptosis. Baba et al (2009) demonstrated the anti-inflammatory effects 
using a rat colitis model in male Wistar rats. Colitis was induced using dextran sodium sulphate 
Stellenbosch University  https://scholar.sun.ac.za
21 
 
 
(DSS), and the authors concluded that rooibos reduced inflammation by decreasing super oxide 
dismutase (SOD) levels in colic rats (Baba et al., 2009). 
 
Kawano et al (2009) demonstrated the amelioration of glucose intolerance and insulin secretion in 
db/db mice with aspalathin introduction. Francisco and colleagues (2010) reported that fermented 
rooibos reduced plasma glucose, low density lipoprotein (LDL) cholesterol, and thiobarbituric 
reactive substances (TBARS) levels, a measure of lipid peroxidation (Janero, 1990). These changes 
led to an increase in the total plasma antioxidant capacity (Francisco et al., 2010). In streptozotocin-
induced (STZ) diabetic rats Muller et al (2012) observed that aspalathin reduced blood glucose levels 
thereby reducing hyperglycaemia. 
 
The protective effects of rooibos on hydroperoxide-induced hepatotoxicity (t-BHP) in male Wistar 
rats, decreased AST and ALT levels (Ajuwon et al., 2013). This was further illustrated by Ulicna et 
al (2008) in CCI4-induced liver damage, causing the histological regression of steatosis and cirrhosis, 
while reducing elevated ALT and AST levels. Marnewick and colleagues (2003) demonstrated that 
continual feeding of aqueous extracts of fermented and unfermented rooibos in male Fischer rats had 
no effects on the antioxidant capacity of the liver. However, it significantly improved glutathione 
(GSH) redox status, by increasing the oxidative markers glutathione (GSH), and reduced glutathione 
(GSSG) (Marnewick et al., 2003). 
 
Serum cholesterol, triglycerides and free fatty acid levels were reduced in rats fed a high fat diet 
following rooibos treatment (Beltran-Debon et al., 2011). Recent studies conducted by Monsees and 
Opawari (2017) reported that rooibos had no effect on the liver, however, the study showed that a 5% 
rooibos aqueous solution caused liver hypotrophy compared to control groups. No necrotic, structural 
or lymphocyte infiltration was observed in the liver (Monsees & Opawari, 2017). Similar 
observations were seen in the kidney; however, serum creatinine levels were higher in fermented 
compared unfermented rooibos treated rats (Monsees & Opawari, 2017). Although rooibos has shown 
attenuating effects in these organs, three cases of hepatoxicity have been reported with excessive 
rooibos consumption presenting as elevated AST and ALT levels (Sinsalo et al., 2010; Engels et al., 
2013; Zacharia & Whitlatch, 2013). 
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Table 2.6: Summary of in vitro studies conducted on fermented and unfermented samples of rooibos. 
Study Rooibos type Effect Cell model Result 
Petrova, 2009 Fermented & 
Unfermented 
Anti-carcinogenic Skin carcinogenic mouse model Reduced incidence and volume of tumours 
reduced oxidative stress 
Beltran-Debon 
et al., 2011 
Fermented Anti-obesity 3T3-L1 mouse adipocytes Inhibited triglyceride accumulation 
Muller et al., 
2012 
Unfermented Anti-diabetic C2C12 and Chang cells Increased glucose uptake and hyperglycaemia  
Schloms et al., 
2012 
Unfermented Anti-inflammatory Transiently transfected CIS-1 cells with 0.1 µg DNA 
(baboon, CYP17A1, CYP21, CYP11B1) 
Decreased total steroid output 4-fold, reduced 
aldosterone, and cortisone precursors 
Dludla et al., 
2014 
Fermented Cardio-protective Ex vivo STZ-induced diabetic rat cardiomyocytes Protected diabetic cardiomyocytes against 
exogenous and ischemic oxidative stress 
Sanderson et al., 
2014 
Fermented Anti-obesity 3T3-L1 adipocytes reduced adipogenesis 
 
Kamakura et al., 
2015 
Fermented & 
Unfermented 
Anti-diabetic Insulin resistant C2C12 muscle cells Reversed palmite induced insulin resistance 
Reactive oxygen species (ROS); Streptozotocin (STZ); Deoxyribonucleic acid (DNA). 
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Multiple in vivo studies on rooibos have been conducted in humans with varying results. A study 
conducted by Sauter (2005) showed no changes in the antioxidant activity using rooibos extracts in 
20 subjects following copper induced low density lipoprotein oxidation. Wanjiku, (2009) agreed that 
no significant changes in antioxidant parameters were met in eight healthy males exposed to an oral 
dose of 500 mL of fermented rooibos. Marnewick et al (2011) reported significant decreases in lipid 
peroxidation, decreased levels of LDL cholesterol, and triglyceride levels with a significant increase 
in high density lipoproteins in humans (n=41) at risk of cardiovascular disease. The discrepancy 
observed in vitro and in vivo studies may be attributed to the bioavailability of rooibos in vivo 
(Marnewick, 2014).  
 
Although numerous studies have demonstrated the potent antioxidant activity of rooibos, the pro-
oxidant effects have also been noted. Joubert et al (2005) demonstrated that pure aspalathin extracts 
compared to aqueous extracts had pro-oxidant activity. Therefore, caution must be taken when 
applying rooibos polyphenols in herbal medicines as the pro-oxidant activity may cause cytotoxicity 
(Marnewick, 2014). 
 
2.4.3 Bioavailability of rooibos 
The effectiveness of any natural compound as a source of antioxidants is dependent on its 
bioavailability (Manach et al., 2005). The bioavailability of a compound refers to its absorption, 
distribution, metabolism and excretion (Manach et al., 2005). Muller et al (2016) stated that the 
efficacy of any flavonoid is based on how it is introduced. The method of introduction could be in 
the form of an aqueous solution that is introduced in drinking water, mixed in feed, orally gavaged 
or added to another compound acting as a vehicle. Muller et al (2016) further stated that the method 
of consumption may be the cause for the discrepancy observed between the action of rooibos in vitro 
and in vivo. 
 
One of the first studies evaluating the absorption of aspalathin was conducted in pigs (n=3) (Kreuz et 
al., 2008). The study used an enriched green rooibos extract mixed in pig feed. The amount of 
aspalathin present in urine and plasma were measured after seven and eleven days. It was found that 
aspalathin was able to pass from the small intestine to the large intestine where the interaction with 
colonic microflora caused the formation an a-glycon and sugar moiety with the subsequent 
breakdown of aspalathin to its c-glucoside forms (orientin and iso-orientin) (Kreuz et al., 2008). 
These results confirmed that aspalathin undergoes glucorondination and methylation allowing 
absorption (Kreuz et al., 2008). No aspalathin was present in serum samples (Kreuz et al., 2008). 
This lack of aspalathin in serum may be attributed to its affinity for plasma proteins (Muller et al., 
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2016). Yet, when the same pigs were given a three times higher dose of aspalathin, trace amounts 
were found in the serum (Kreuz et al., 2008).  
 
The synergistic action of aspalathin and its flavonoids may assist in the bioavailability of aspalathin 
(Muller et al., 2016). Using a Caco-2 monolayer cell model, Huang et al (2008) demonstrated that a 
green rooibos extract was a better model for aspalathin absorption compared to a pure aspalathin 
extract. Using the same model, Courts and Williamson (2009) concluded that aspalathin uses passive 
diffusion in intestinal epithelium, thus, the actions of the other polyphenols in rooibos allows for 
greater absorption.  
 
The poor bioavailability of aspalathin may be due to the fact that it does not follow Lipsinki’s Rule 
of Five (Lipsinki et al., 2012; Muller et al., 2016). For any drug or therapeutic agent to be bioactive 
or pharmacologically active Lipinski’s Rule of Five must be considered. This rule refers to the 
multiples of five and not the number of rules. In general, the rule sates that orally active substance 
must not violate more that one of the following criteria: It must have no more than five hydrogen 
bonds (aspalathin has nine hydrogen bonds). No more than ten hydrogen bond acceptors (aspalathin 
has 11 hydrogen bond acceptors). Aspalathin must have a molecular mass less than 500 daltons 
(aspalathin is 453 daltons). Finally, aspalathin must have Log P>5 (aspalathin Log p=-0.322). Despite 
aspalathin violated two of the four rules, rooibos and its polyphenols remain attractive therapeutic 
options to alleviate oxidative stress in biological systems; therefore, importance should be placed on 
the study of rooibos and its polyphenols (Joubert et al., 2011). 
 
2.5 ORGAN SYSTEMS: HISTOLOGY AND PATHOLOGY  
2.5.1  Pancreas histology 
The rodent pancreas is a highly diffuse, multilobulated structure that spreads from the end of the 
duodenal loop into the gastrosplenic omentum (Kara, 2006). Topographically, the rat pancreas can 
be observed with the removal of the stomach and duodenum. Once these structures are removed three 
distinct portions are seen namely the biliary, duodenal and gastrosplenic portions (Kara, 2005). 
 
Histologically, the pancreas consists of both exocrine and endocrine parts that differ in terms of 
structure and function (Kierszenbaum & Tres, 2015). The functional unit of the exocrine pancreas is 
the acinus, which secretes digestive enzymes (Wieczorek et al., 1998; Young et al., 2006; 
Kierszenbaum & Tres, 2015). The acinus is a pyramid shaped cluster of secretory cells that surround 
the centroacinar cells, recognised by their central location and pale staining nuclei in the lumen 
(Kierszenbaum & Tres, 2015). Each centroacinar cell is surrounded by the acinar cells, of which the 
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apical portion is occupied by dark staining zymogen granules containing the pancreatic enzymes 
(Kierszenbaum & Tres, 2015). These cells are continuous with the duct systems forming the 
intercalated ducts, the smallest tributary of the duct system, followed by the intralocular ducts and 
the interlobular ducts. These ducts are differentiated by the amount of connective tissue. The bigger 
the duct, the more connective tissue (Young et al., 2006; Kierszenbaum & Tres, 2015). 
 
Both the exocrine and endocrine portions are highly vascularised and are supplied by the acinar 
vascular system and insuloacinar portal systems, respectively (Kim et al., 2009; Kierszenbaum & 
Tres, 2015). Different types of models have been proposed for islet microvasculature, mainly the 
mantle to core, core to mantle and artery to vein models, which differ according to the cell types and 
their function within the pancreatic islets (Murakami et al., 1997; Kim et al., 2009). However, this is 
beyond the scope of this research.  
 
Embedded within the exocrine tissue are the pancreatic islets forming approximately 2% of the total 
organ mass (Wieczorek et al., 1998). Each islet is surround by a delicate capsule made up of reticulin 
fibres and is formed by anastomosing cords of endocrine cells. These endocrine cells include 
glucagon secreting α-cells, insulin secreting β-cells, somatostatin secreting δ-cells and pancreatic 
polypeptide secreting PP-cells (Elayat et al., 1995; Wieczorek et al., 1998; Young et al., 2006; 
Kierszenbaum & Tres, 2015). Each islet in the human and rat vary in terms of composition, 
architecture, location, and size (Figure 2.7) (Wieczorek et al., 1998; Steiner et al., 2010). 
 
In humans, the α-cells form the majority (82%) of the islet, compared to β-cells (13%), δ-cells (4%), 
and PP-cells which comprise the minority (1%) (Steiner et al., 2010). The various cells types are 
dispersed within the islet and do not form a specific pattern. Various studies have noted that the 
composition of pancreatic islets may vary according to location within the organ. Brissova et al 
(2005) demonstrated that the body, neck, and tail portions of the pancreas contained greater numbers 
of α-cells and β-cells, whereas the head portion had a greater number of PP-cells. Kim and colleagues 
(2009) noted that smaller islets have a larger number of β-cells in comparison to larger islets.  
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Figure 2.7: Graphical representation of the islets of Langerhans. A) shows the variation in human and rat 
pancreatic islets, rat pancreatic islets show insulin secreting β-cells forming the majority, and are surrounded 
at the mantle by the glucagon secreting α-cells. Dorsal aspect of the islet contains several PP-cells with few δ-
cells. In the human islets, the various cells are dispersed throughout the islet and do not follow a specific 
pattern Adapted from (Suckale et al., 2008); B) a double immunohistochemically labelled rat pancreatic islets 
using insulin and glucagon antibodies to identify α-cells and β-cells within the pancreatic islet embedded 
within the acinus (black arrows) (100x magnification) bar=100 µm. 
 
Unlike human islets, the rat islet is predominately composed of β-cells (forming 60-80% of the total 
islet mass), followed by the α-cells (15-20%), δ-cells (<10%) and PP-cells (1%) (Steiner et al., 2010). 
On two-dimension histological sections the pancreatic islets show α-cells forming a continuous 
mantel around a core of β-cells (Wieczorek et al., 1998; Steiner et al., 2010). Like humans, a 
significant difference in the number of islets were present in different regions of the rat pancreas. 
Eleyat et al (1995) noted that PP-cell rich islets were predominantly found in duodenal portion of the 
pancreas while α-cell rich islets were mainly situated in the upper duodenal, gastric, and splenic 
portions. The size of the islets vary throughout the pancreas (Eleyat et al., 1995). One of the 
resounding notes stated by Kim et al (2009) and Steiner et al (2010), is that the pancreas is not a static 
structure and is able to respond to various physiological conditions and that islet structure and 
architecture is compromised in various pathological conditions.  
 
2.5.2 Pancreas pathology  
The pancreas is prone to various metabolic changes affecting both the exocrine and endocrine portion. 
Damage to the exocrine portion of the pancreas is termed pancreatitis of which there are two forms, 
namely acute and chronic (Cross, 2013). Pancreatitis generally refers to inflammation of the pancreas 
which may develop due to infection, hyperlipidaemia, trauma, alcohol abuse, or with the use of 
certain drugs (Cross, 2013). Zhang and colleagues (2010) demonstrated the early manifestation of 
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damage in a pancreatitis induced rat model. The pancreas presented with mild inflammatory cell 
infiltration, intestinal congestion and oedema, including instances of focal necrosis (Zhang et al., 
2010). The continuation of this insult to the pancreas leads to chronic pancreatitis which may result 
in fibrosis or complete destruction of pancreatic tissue (Kierszenbaum & Tres, 2015).  
 
The endocrine portion may be affected by immunosuppressive drugs tacrolimus and cyclosporine 
leading to degenerative changes of pancreatic islets (Drachenberg et al., 1999). These degenerative 
changes present as cytoplasmic changes and vacuolations of β-cells (Drachenberg et al., 1999). In 
STZ induced diabetic rats, Adewole et al (2007) noted the breakdown of micro-anatomical features, 
namely the dysregulation of β-cells, decreased cellular density, and necrotic changes. In STZ treated 
mice, Michels et al (1986) noted a higher volume of pancreatic islets however, the study noted 
decreases in β-cell volume compared to controls.  
 
It should further be noted that all these disease states may be a result of oxidative stress. The β-cell is 
particularly prone to oxidative stress as these cells contain very low levels of natural antioxidants 
(Sakuraba et al., 2002). These disease states demonstrate the morphological changes and 
histopathological representations that may occur. 
 
2.5.3  Liver histology 
The liver is multifunctional metabolic organ, where fats are oxidised to triglycerides producing 
energy and plasma lipoproteins are synthesised forming cholesterol and phospholipids (Young et al., 
2006). Through the actions of glycogenesis, glycogenolysis and gluconeogenesis, the liver is able to 
regulate blood glucose concentrations, and metabolise carbohydrates to fatty acids and triglycerides 
(Young et al., 2006). It further functions to synthesize and produce plasma proteins, clotting factors, 
and non-essential amino acids. In addition, the liver functions to eliminate and detoxify various drugs 
and toxins including alcohol. In this regard the liver plays an important role in drug metabolism 
(Young et al., 2006). 
 
The rat liver consists of four lobes, namely the median lobe, caudate lobe, right lateral lobe and left 
lateral lobe (Suckow et al., 2005). One of the main differences between the rat and human liver is 
that the former lacks a gall bladder. In rats the bile ducts from each caudate lobe, anastomose forming 
the common bile duct (Suckow et al., 2005). Although, anatomically the number and pattern of the 
liver lobes varies between species, histologically the liver follows a similar structure.  
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There are two types of cells in the liver, namely the parenchymal cells which are the hepatocytes and 
non-parenchymal cells (Kupffer, stellate and endothelial cells) (Bouwens et al., 1992; Wisse et al., 
1996). Hepatocytes are the pyramidal or rounded shaped cells that form the bulk of the liver 
parenchyma (80%) and provide both exocrine and endocrine functions (Baratta et al., 2009). These 
cells are generally mononucleated; however, binucleated hepatocytes are common as well (Gupta, 
2000). A network of collagen type I, II and III, IV and V is found throughout the liver and is 
particularly rich in type III reticulin fibres, providing an architectural base in which the hepatocytes 
sit (Kierszenbaum & Tres, 2015). The hepatocytes form the limiting plates of the hepatic sinusoids. 
Kupffer cells are predominantly found within the blood sinusoids, however the cells are more 
frequent around the periportal areas (Wisse et al., 1996). Separating the blood sinusoids from the 
hepatocytes is the space of Disse (Kierszenbaum & Tres, 2015). Of which some of the non-
parenchymal cells such as stellate cells (peri-sinusoidal cells) are found (Wisse et al., 1996). These 
cells are activated in the early stages of liver injury (Wisse et al., 1996). Finally, endothelial cells 
line, blood vessels and sinusoids within the liver (Kierszenbaum & Tres, 2015).  
 
The structural and functional unit of the liver is the hepatic lobule. The classical structure of the 
hepatic lobule is discerned by the central vein surrounded by six portal triads forming a hexagon 
(Figure 2.8) (Young et al., 2006; Kierszenbaum & Tres, 2015). The classic hexagonal shape of the 
lobule is not easily seen in the human or rat however, this structure is clearly defined in other 
mammals including the pig (Kierszenbaum & Tres, 2015). The portal lobule is defined by three 
central veins where the bile canaliculi drain into the same bile duct forming, the hepatic lobule (Cross, 
2013). The final structure of the liver and commonly referred to in pathology, is the liver acinus. The 
liver acinus is the smallest functional unit of the liver and is structured based on arterial blood flow 
between bordering central veins and the portal triad. Essentially, the acinus is made up of two wedged 
shaped masses consisting of a portal triad at the centre and are surrounded by two neighbouring 
central veins. Each acinus consist of three zones; zone one (periportal region) consisting of highly 
oxygenated hepatocytes, zone two (midzonal) forming the intermediate layer, and zone three 
(centrilobular) consisting of poorly oxygenated hepatocytes prone to hypoxia (Kierszenbaum & Tres, 
2015).  
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Figure 2.8: Graphical representation of the functional units of the liver. The hepatic lobule is the 
hexagonal shaped structure (orange) consisting of a central vein (large blue circle) at the centre and is 
surrounded by the portal triad (triangle shaped circles) consisting of the hepatic vein (small blue circle), hepatic 
artery (red circle) and bile duct (green circle). The portal lobule (large purple triangle) is formed by the central 
veins which drain into a single central bile duct. The acinus (pink oval) is formed by neighbouring central 
veins and consist of three zones, zone three closest to the central vein and zone one is the furthest from the 
central vein. 
 
2.5.4 Liver pathology 
The liver is a highly regenerative organ and able to adapt quickly to stressors (Nayak et al., 1996; 
Michanalopoulos, 2007). However, due its multifunctionality, the liver is prone to various types of 
damage, for the majority of this section focus is placed on the diagnosis of hepatic liver injury as a 
result of drug administration. It should be noted that these liver injuries all follow a common pathway; 
generally resulting in fibrotic changes (Alcolado et al., 1997), unless these insults lead to degenerative 
changes such as necrosis. The major histological lesions in the liver are fatty changes, hepatocellular 
death or hepatobiliary lesions (Amacher, 1998). There are two types of fatty changes, namely 
microvesicular or macrovesicular steatosis, which are differentiated by the displacement of the 
nucleus (Amacher, 1998). Microvesicular steatosis is characterised by the formations of small lipid 
vacuoles within the cytoplasm of hepatocytes. Generally, this formation does not cause the 
displacement of the nucleus. Macrovesicular steatosis is described as the formation of one large lipid 
vacuole displacing the nucleus of the hepatocytes (Amacher, 1998). Another form of damage that 
may result, is fibrosis. Fibrosis is characterised by an increase collagen fibres within the parenchyma 
(Alcolado et al., 1997). With increasing severity fibrosis, will result in cirrhosis (Cross, 2013). One 
of the principle staining techniques used to observe fibrosis in the liver is Masson’s trichrome stain, 
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which is able to distinguish type I collagen fibres allowing histopathologists to examine the extent of 
the fibrotic change (Saxena, 2010). Cellular damages will occur where large portions of the liver 
parenchyma are disrupted leading to necrosis. Necrosis leads to the severe disruption and subsequent 
collapse of liver architecture specifically reticulin fibres. The reticulin stain is routinely used by 
histopathologist to examine the extent of architectural damage and regeneration occurring in the liver 
(Saxena, 2010).  
 
Liver injuries share common diagnostic feature in that they lead to liver enzyme elevations 
specifically ALT and AST. These serum biomarkers are the gold standard in determining liver 
toxicity and are the single most commonly used diagnostic feature for hepatocellular injury 
(Amacher, 1997; Ozer et al., 2008). When damage occurs hepatocytes release ALT and AST into the 
extracellular space, thus entering circulation (Ozer et al., 2008). Both these serum markers provide 
an indication of damage in other areas of the body, for example AST may also be used as a biomarker 
for heart and skeletal muscle injury, while ALT may be used as marker for muscle necrosis (Nathwani 
et al., 2005). However, it is the ratio of AST:ALT that allow pathologists to determine liver injury 
from other types of tissue damage (Ozer et al., 2008). Serum AST and ALT are routinely used 
diagnostic features used in experimental and clinical studies, and are often referred to in studies 
evaluating the liver (Siest et al., 1975). 
 
2.5.5 Kidney histology 
The kidney forms part of the urinary system and primarily functions to filtrate and excrete waste 
products (Kierszenbaum & Tres, 2015). It regulates blood and water homeostasis through the 
absorption of small molecules, such as amino acids and glucose (Kierszenbaum & Tres, 2015). 
Through the renin-angiotensin-aldosterone system the kidney maintains blood pressure (Young et al., 
2006; Cross, 2013; Kierszenbaum & Tres, 2015). Due to its many functions, the kidney is comprised 
of unique systems of complex structures allowing for the filtration and excretion of waste products 
from the blood (Cross, 2013). 
 
The urinary system of the human and rat comprises of two paired bean-shaped kidneys (Green, 1955). 
Anatomically, the rat kidney is unilobular while the human is multilobular (Kierszenbaum & Tres, 
2015). However, the kidney does not vary histologically and is composed of four distinct segments 
divided into a cortex and medulla. The cortex is further divided into the outer cortex and medullary 
cortex and then into the outer and inner medulla (Young et al., 2006; Kierszenbaum & Tres, 2015). 
The medulla consists of cone or pyramid shaped structures that form the renal medullary pyramid. 
The pyramid extends from the calyx to the cortex, forming the corticomedullary zone (Kierszenbaum 
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& Tres, 2015). The renal medullar pyramids to the corticomedullary zone form the renal lobe (Young 
et al., 2006; Kierszenbaum & Tres, 2015) these structures form the bulk of the kidney.  
 
Blood is supplied to the kidney by a single renal artery, consisting of a dorsal and ventral branch, 
which in turn, subdivide into the cranial and caudal branches (Yoldas & Dayan, 2014; Kierszenbaum 
& Tres, 2015). These vessels then branch out into the juxtamedullary cortex forming the arcuate 
arteries (Kierszenbaum & Tres, 2015). These arteries then ascend into the cortex forming the 
interlobular arteries and afferent arterioles giving rise to the glomerular capillary network 
(Kierszenbaum & Tres, 2015). This unique network of glomerular capillaries, form a part of the 
nephron. The nephron is the functional unit of the kidney and is comprised of the renal corpuscle and 
renal tubules (Young et al., 2006).  
 
Situated within the cortex is the spherical-shaped renal corpuscle, which is composed of a glomerulus 
surrounded by a Bowman’s capsule (Young et al., 2006; Calado, 2013). The glomerulus is a mass of 
anastomosing glomerular capillaries that are situated within the renal space (Kierszenbaum & Tres, 
2015). The glomerulus is composed of the glomerular capillaries, podocytes and the mesangium (a 
mixture of mesangial cells and mesangium matrix) (Kierszenbaum & Tres, 2015). The Bowman’s 
capsule is made up of visceral and parietal layers, it is the parietal layer that forms the basement 
membrane of the capsule. The renal space is the space between the visceral and parietal layer of the 
Bowman’s capsule which is generally filled by plasma ultrafiltrate (Young et al., 2006; Calado, 2013; 
Kierszenbaum & Tres, 2015). The renal space is continuous with the second portion of the nephron, 
the renal tubule (Young et al., 2006; Kierszenbaum & Tres, 2015).  
 
The renal space joins with the PCTs which descend into the medulla forming the loop of Henle, which 
then ascend back to the cortex forming the distal convoluted tubules (DCT). Via a connecting tube, 
the DCTs attach to the collecting duct. Facing the afferent and efferent arterioles is an area of dense 
cells termed the macula densa, which form part of the DCT (Kieszenbaum & Tres, 2015). 
 
The PCT and DCT are distinctly different, and can be differentiated by the pattern of the epithelial 
cells, and the presence or absence of a brush border (Young et al., 2006; Kierszenbaum & Tres, 2015). 
The brush border allows for a substantial increase in the absorption capacity of the PCT. Due to the 
high glycogen content of the brush border, the periodic acid schiff (PAS) stain provides a good 
indication of the differences between the PCT and DCTs. Due to the increased mitochondria within 
the cytoplasm, the PCTs generally stain more intensely using the PAS method. Situated within the 
cortex, amongst the PCTs, are the DCTs. These tubules arise from the ascending limb of the loop of 
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Henle and are distinguished from the PCT by the clearer larger lumen, increased number of nuclei 
and the absence of a brush border (Young et al., 2006; Kierszenbaum & Tres, 2015). The various 
functions of the kidney will determine the resulting injurious lesion and the structure affected in the 
kidney.  
 
2.5.6 Kidney pathology 
The nature of the kidney is highly complex; thus, the resulting pathology may affect various 
structures. Figure 2.9 summarises the types of diseases affecting the glomerular corpuscle and PCT. 
The size and width of the glomerulus is implicated in various diseases (Kotyk et al., 2015). These 
injuries present as increased glomerular surface area and expansion of the renal space due to a 
thickening basement membrane. These have been observed in numerous pathological conditions 
including drug induced toxicities. Glomerular disease may occur as a consequence of a high fat diet, 
diabetes, blood pressure, or drug use. A study conducted by Goumenos et al (2009) on obese 
individuals, found that obese patients presented with enlarged glomeruli and early stages of diabetic 
nephropathy. In rats, large intravenous doses of human basic fibroblast growth factor (FCE 26184) 
resulted in enlarged and vacuolated podocytes and cast formation in the PCT and DCT (Mazué et al., 
1993). In STZ-induced diabetic rats the kidneys presented with increased glomerular volume, tubule 
length and volume compared to the control animals (Rasch & Dørup, 1997). A similar study noted 
an enlarged renal space with thickening of tubular and glomerular basement membranes in obese 
dogs compared to controls (Henegar et al., 2001). A study evaluating drug toxicity of cyclosporine 
and FK505 (antibiotics) noted that short term drug toxicity was associated with PCT and DCT 
vacuolations not exceeding 20% of the total diameter (Randhawa et al., 1993). Thus, various injures 
may lead to quantitative and qualitative measurable changes within the kidney.  
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Figure 2.9: Described are the various kidney diseases and their pathological features. It should be noted 
that focal segmental glomerulonephritis is associated with HIV. Glomerular basement membrane (GBM); 
Proximal convoluted tubule (PCT); Distal convoluted tubule (DCT); Electron microscopy (EM); Glomerulus 
(GLOM). 
 
With this information, it is clear that the histological effects of ART in rodent models is 
underreported. Furthermore, questions arise on whether ADRs are the result of ART or exacerbated 
by external variables. Reports on the antioxidant and therapeutic potential of rooibos promotes its 
study at a histological level.   
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3.1 RESEARCH QUESTIONS  
• Does ART have a histologically discernible damaging effect on the histology of the pancreas, 
liver, and kidney? 
• If so, what is the extent of the histological damage in the various organs?  
• Does the administration of rooibos (A. linearis) tea, attenuate the potentially damaging effects 
of the antiretroviral drug combination (Efavirenz, Emtricitabine, and Tenofovir) on the 
histology of the pancreas, liver, and kidney in male Wistar rats? 
 
3.2 AIM 
To assess the effects of antiretroviral drugs, and rooibos tea on the histology of the pancreas, liver, 
and kidney in the male Wistar rat. 
 
3.3 OBJECTIVES  
To achieve the above mentioned aim the following steps will be taken:  
1. To histologically assess the morphology of the pancreas and kidney using light microscopy 
and quantitative morphometric measurements in the following four groups: 
• Untreated control (C); 
• Control animals receiving ART (C-ARV); 
• Control animals receiving rooibos tea (C-R); 
• Experimental animals receiving ARV drugs and rooibos tea (ARV+R). 
2. To analyse the pancreas, liver, and kidney for pathology using semi-quantitative methods of 
grading and scoring in the four treatment groups. 
3. To measure blood glucose levels in the four experimental groups and to compare differences 
between the groups. 
4. To measure alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels 
including the ratio of ALT:AST of the four experimental groups and to compare the 
differences between these groups. 
 
3.4 HYPOTHESES 
H0: Rooibos does not have a restorative effect on the histomorphology of the pancreas, liver, and 
kidney of male Wistar rats following antiretroviral therapy. 
 
Ha: Rooibos has restorative effects on the histomorphology of the pancreas, liver, and kidney of male 
Wistar rats following antiretroviral therapy.  
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4.1 ETHICAL APPROVAL 
Ethical approval for the following study has been obtained from Stellenbosch University Research 
Ethics Committee. Ethical approval was granted for the housing of animals under SU-ACUD14-
00021, and for the use of animal tissue under the ethics number SU-ACUD15-0003. 
 
4.2 STUDY GROUPS AND ANIMAL CARE 
Male Wistar rats (Rattus norvegicus) (N=40) were obtained from the Central Animal Unit of the 
Faculty of Medicine and Health Sciences of Stellenbosch University. The rats were randomly selected 
and sorted into four groups. Three groups of control animals were prepared, consisting of untreated 
control (C) (n=10), rooibos control (C-R) (n=10) and ART control (C-ARV) (n=10) rats. Finally, one 
experimental group was prepared, receiving a combination of ART and rooibos tea (ARV+R) (n=10) 
(Figure 4.1).  
 
Housing and care of the rats were conducted ethically and under the conditions set out by the Research 
Ethics Committee: Animal Care and Use (REC: ACU) of Stellenbosch University using the South 
African National Standards (SANS) document. Rats were reared as pups for four weeks, and kept 
under observation for signs of stress, illness, or injury for a period of two weeks on standard breeders 
feed (Nutritionhub (Pty) Ltd, Stellenbosch, South Africa) and water until reaching a weight of 180 g. 
The animals then underwent experimentation for nine weeks prior to euthanasia. The life span of the 
rats totalled 15 weeks. 
 
During experimentation, rats were housed at room temperature (± 23 ºC) following 12-hour light and 
dark cycles (06:00 to 18:00) with 40% humidity at the Central Research Facility, Stellenbosch 
University. All groups had access to standard breeders feed, consisting of 1.272 kJ/100 g and water 
or rooibos tea ad libitum from the start of the intervention. 
 
4.3 ANTIRETROVIRAL ADMINISTRATION 
Weight dependent dosage of one Odimune© (Cipla Medpro (Pty) Ltd, Bellville, Western Cape) Tablet 
containing 600 mg Efavirenz, 200 mg Emtricitabine, and 300 mg Tenofovir was administered to C-
ARV and ARV+R groups.  
 
Antiretroviral dosage for the rats was calculated per the guidelines set out by the United States Food 
and Drug Administration (Centre for Drug Evaluation and Research, 2005). Specific doses were 
calculated using the average weight of the rats in individual cages. A final dose of 51.6 mg/kg/day of 
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EFV, 17.4 mg/kg/day of FTC, and 25.8 mg/kg/day was given to the rats. This was then multiplied by 
the weight of the rat. Exact dose and weight calculations are supplied in Appendix C. 
 
Single Odimune© tablets were crushed and suspended in 1 mL water and thoroughly vortexed. Each 
prepared sample was refrigerated at 4 °C and administered via oral gavage daily to C-ARV and 
ARV+R groups. The C and C-R groups were gavaged using tap water to maintain consistency 
between animals. Gavage was conducted by a professional technician at the animal unit of 
Stellenbosch University.  
 
4.4 SUPPLEMENTATION OF ROOIBOS 
Dried rooibos (A. linearis) leaves were obtained from the Carmién© tea company Pty, Ltd 
(Brakfontein, South Africa). A 2% aqueous solution was made using 20 g of fermented (red tea) 
rooibos leaves and added to 1 L boiling water. Leaves were steeped for 30 min, filtered through a 
layer of cheese cloth, followed by Whatman No.4 and No.1 filter papers. The preparation was stored 
in light limiting bottles and wrapped in aluminium foil per the methods described by Marnewick et 
al., 2003. This limited the effects of light exposure to the polyphenols in the tea, as light exposure is 
known to cause decreased levels of polyphenols. The tea was provided in place of water to the C-R 
and ARV+R groups. Fluid intake of the animals was measured and recorded weekly. 
 
4.5 PROCEDURES  
4.5.1 Anaesthesia and euthanasia 
Prior to harvesting, animals were weighed using an automated scale. Anaesthesia was administered 
via intra-peritoneal injection using sodium pentobarbitone (Eutha-naze©, Bayer (Pty), Ltd, Isando, 
Gauteng) at a dose of 2 mg/mL/kg prior to surgery. Anaesthesia was conducted by a trained 
professional authorised by the South African Veterinary Council (SAVC). Full anaesthetisation was 
ascertained by testing pedal, withdrawal, and corneal reflexes.  
 
4.5.2 Tissue harvesting 
Tissue was received from the Medical Physiology Department of Stellenbosch University, Faculty of 
Medicine and Health Sciences from a study entitled: Effect of Aspalathus linearis supplementation, 
during anti-retroviral treatment, on the heart and aortas of male Wistar rats and the effects of drinking 
rooibos on the cardiovascular profile of patients on ART (Imperial, 2017). This study forms part of 
the aim to minimise the impact of experimentation on animals and to acquire as much information as 
possible from organs that would otherwise be discarded after death. 
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Tissue was harvested nine weeks from the start of the experiment. Once fully anaesthetised the heart 
was removed rendering the animal dead. The abdominal cavity was exposed allowing for the removal 
of the pancreas, liver, and left kidney. A portion of the left lateral lobe was dissected and immediately 
placed in 5% paraformaldehyde fixative. The pancreas was immediately placed in the fixative once 
removed to immediately suspend the autolytic process. The left kidney was transversely halved prior 
to placement in the fixative allowing for maximum infiltration of the fixative. 
 
4.5.3 Blood sampling  
Once the abdominal cavity and thoracic cavity were open and the heart removed, blood was harvested 
from the abdominal and thoracic cavity using disposable pasteurised plastic pipettes and placed into 
MiniCollect® 1 mL red top serum tubes (The Scientific Group, (Pty), Ltd, Milnerton, Western Cape). 
Within two hours of blood collection, the clotted blood samples were centrifuged at 1 300 revolutions 
per minute for 20 minutes using a Biofuge pico centrifuge (Heraeus, Kendro Laboratory products, 
Germany). Blood serum was collected from each tube using a P100 micro-pipette and stored at -80 
°C in preparation for blood analysis. The prepared serum samples were sent to the National Health 
Laboratory Services (NHLS) at Tygerberg Hospital, where aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) levels were tested under NHLS standard operating procedures 
(Appendix D). An AST:ALT ratio was calculated to determine liver function.  
 
4.6 HISTOLOGICAL PROCEDURES 
Fixed portions of the of the pancreas, liver, and kidney were added to labelled embedding cassettes 
and processed under standard histological procedures, using the Shannon Elliot Duplex Processor 
(OptoLaboratory, Cape Town). Tissue was processed to ensure complete dehydration and rigidity for 
sectioning (Appendix E). Processed tissues were embedded in paraffin wax using the Leica EG 116 
Embedder (SMM instruments, Germany). The tissue blocks were then placed in the freezer to cool 
for 20 minutes before sectioning. A Leica RM 2125 RT microtome (SMM Instruments, Germany) 
was used for sectioning of the various tissues.  
 
4.6.1 Sectioning and staining of the pancreas 
Pancreatic sections were prepared in duplicate for routine automated haematoxylin and eosin (H&E) 
stain using the Leica Auto Stainer XL (SMM Instruments, Johannesburg) (Appendix F) and standard 
immunohistochemistry labelling techniques. Tissues that were sectioned at 5 µm were placed on 
frosted slides and stained using H&E. Immunohistochemical labelling of pancreatic tissue was 
conducted per the standard operating procedures of the South African Medical Research Council 
(MRC), ICC\B7-V01 (Appendix G). Due to the specificity of the immunohistochemistry stain, the 
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pancreas was sectioned at 3 µm and placed on positively charged slides, which allowed for the 
complete infiltration of the stain into pancreatic tissue.  
 
A standard double labelling immunohistochemical (IHC) approach was conducted using the Dako 
EnVision G/2 system/AP rabbit/mouse link (K5355, Dako, Denmark, Inc), using anti-insulin and 
anti-glucagon antibodies. The EnVision kit is specifically recommended for detecting antigens at 
very low concentrations. Sections of pancreas were deparaffinised and dehydrated to water which 
allowed for the even distribution of the stain. Following the blocking of endogenous peroxidases 
using 3% hydrogen peroxide (Merck (Pty) Ltd, Modderfontein, Gauteng), a 1:20 dilution of normal 
goat serum (NGS) was applied to block charged sites. Slides where then placed in a moisture chamber 
for 30 minutes to prevent drying out of reagent. Once the excess serum was blotted, a 1:100 dilution 
of the polyclonal anti-glucagon primary antibody was added binding to the antigen of interest (K5355, 
Dako, North America, Inc) and incubated at room temperature for 30 min. Sections were then jet 
washed and a 1:200 dilution of the biotinylated goat anti-rabbit IgG and Vectastain ABC 
(VectorLaboratories, Ak-5010) was applied, sections were incubated for one hour in a moisture 
chamber. Sections were then dried around the edges and the liquid DAB-Chromogen solution 
(K5355, Dako, North America, Inc) was applied for visualisation of the antigen-antibody complexes. 
Slides were then jet washed and rinsed and a 1:20 dilution of Normal Horse Serum (NHS) was 
applied. Once complete a 1:10 000 dilution of the monoclonal anti-insulin antibody (K5355, Dako, 
North America, Inc) was added and incubated overnight at 4 °C. Following incubation, a biotinylated 
rabbit/mouse link (K5355, Dako, North America, Inc) was applied. The EnVision and AP Enhancer 
(K5355, Dako, North America, Inc) were used to observe the antibody labelling. Pancreatic tissue 
from the control group was used as an internal positive control for the staining procedure. External 
and internal positive controls were used to validate the stains. This technique labels insulin secreting 
β-cells pink/red and glucagon secreting α-cells brown (Figure 4.2). 
 
4.6.2 Sectioning and staining of the liver  
Four slides at different specified section thicknesses were made for hepatic tissue, which allowed for 
various staining techniques to be applied. To ensure that different areas of the liver were studied a 15 
µm trim was made between sections. Haematoxylin and eosin stains were made for each animal, on 
a 5 µm tissue sections, using the Leica Auto Stainer XL. The H&E stain was used to control for all 
the special stains applied to the tissue, as well as acting a primary reference point for any observable 
pathology.  
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The Gordan and Sweet silver impregnation technique was applied to 4 µm thick sections and placed 
on positively charged slides (Appendix H). Positively charged slides were used to allow maximum 
adherence of the silver solution to the tissue for a more robust stain. This technique stains reticulin 
fibres black, and was used to determine subtle architectural changes that would otherwise not be 
observable in the H&E stained tissue. A Periodic Acid Schiff (PAS) stain was applied to 4 µm thick 
sections (Appendix I). The PAS stain is routinely used to determine glycogen deposits in liver 
sections as glycogen accumulation may signify pathology. Finally, a Masons Trichrome (MT) stain 
was applied to 5 µm thick sections. Masson’s Trichrome is routinely used by histopathologists to 
determine fibrotic changes associated with liver pathology (e.g. fibrosis). This stain is used to 
differentiate smooth muscle fibres and stains collagen type I blue (Appendix J). These stains were 
applied to observe the potential progression of liver pathology by staining various histological 
structures. Human skin was used as an external positive control for the MT and silver impregnation, 
as skin contain high amounts of collagen. Rat colon was used as an external positive control for PAS. 
The C-group was used as an internal control for all stains.  
 
4.6.3 Sectioning and staining of the kidney  
Two slides, 5 and 3 µm thick, were made for the kidney. To ensure that different parts of the kidney 
were studied, 15 µm trims were made between sections of tissue. Tissue was stained using H&E and 
PAS. In the kidney, PAS was used to stain the basement membrane magenta, and nuclei blue. This 
stain specifically allowed for better differentiation of the proximal and distal convoluted tubules. 
Periodic Acid Schiff is routinely used by histopathologists to identify impairments in the basement 
membrane. Rat colon was used as an external positive control for PAS, sections acquired from the C-
group was used as internal positive controls. 
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Figure 4.1: Summary of methodology. Male Wistar rats were divided into four groups where the pancreas, liver, and kidney were removed. Each tissue was subjected 
to haematoxylin and eosin staining as well as other various immunohistochemical and special stains. Each organ was morphometrically analysed and graded and 
scored for pathology. Additionally, liver function tests, aspartate and alanine aminotransferase, were performed.
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4.7 STEREOLOGY AND MORPHOMETRY 
Each tissue section was examined under the light microscope, using a Nikon Eclipse Ti Automated 
scanning microscope (Nikon Instruments Inc, Walt Whitman Road Melville, New York) with inbuilt 
camera (Nikon Digital Sight DS-Fic, Nikon corporation, Japan). The analytical techniques differed 
with each organ which are further elaborated in Sections 4.7.1-4.7.3. 
 
4.7.1 Pancreas 
Immunohistochemically labelled sections of the pancreas were captured using a 10 x objective lens 
in conjunction with the Nikon NIS Imaging Software version 4.40 (Nikon Instruments Inc, Copyright 
1991-2015). The whole section was scanned with a 15% overlap area. Once scanning was complete 
the images were stitched forming a complete image of the total section.  
 
To quantify the amount of glucagon-and insulin-positive cells, sections of the pancreas were subject 
to a red/green/blue colour segmentation. This caused images to be converted to a binary image. The 
total section areas and the total islet areas (µm2) were determined. The total islet number was 
quantified using the Leica Qwin professional software (Leica Microsystems, United Kingdom), which 
was calibrated to 0.7 µm/pixel. The software was additionally used to determine the specific areas 
(µm2) of glucagon positive α-cells (brown) and insulin positive β-cells (red) within each islet (Figure 
4.2). The area of β-cells and α-cells was expressed as a percentage of the total islet area. Due to the 
percentage overlap that occurred during image capturing, islets that fell in the borders of the 
micrographs were excluded thereby preventing double analysis of the islets. 
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Figure 4.2: Morphometric analysis of the islets of pancreatic islets using immunohistochemical labelling.  
A) Demonstrates a pancreatic islet in a control animal, with α-cells (labelled brown with anti-glucagon 
antibodies) and β-cells (labelled pink/ red with anti-insulin antibodies; B) The surface area of the islet were 
measured in µm2 (red) by drawing around the perimeter of the islet; C) Using colour segmentation the area of 
α-cells (green) were highlighted then quantified; D) The area of β-cells (blue) are quantified. Bar=50 µm, 100 
x objectives. 
 
4.7.2 Liver  
Liver sections were photographed at 100 x magnification with the Nikon NIS Imaging software 
version 4.40 (Nikon Instruments Inc, Copyright 1991-2015) for subtle pathology. The tissue section 
was graded and scored as described in Table 4.1. An average score was obtained from all the stains 
used and compared between the various groups. The H&E stains were used as a confirmatory slide 
for overall pathology. First, the whole tissue section of each stain was evaluated, then by lobule, 
followed by the portal areas, central vein and hepatocyte. Evaluators of pathology were blinded as to 
which group was under study. The histological features were grouped into three main categories 
namely architectural, glycogen, and fibrotic changes. Trends in areas affected were noted. Disruptions 
were evaluated and the severity of the disruption was scored. 
 
 
Stellenbosch University  https://scholar.sun.ac.za
45 
 
 
Table 4.1: Definitions and scoring of liver pathology. 
 
4.7.3 Kidney 
Sections of the kidney were photographed at 200 x magnification with Nikon NIS Imaging Software 
version 4.40 (Nikon Instruments Inc, Copyright 1991-2015). Kidney sections stained using PAS were 
scanned with a 15% overlap in the images. Images were stitched forming a composite image of the 
whole section.  
 
Once all individual photographs were obtained, a total of 30 glomerular corpuscles were randomly 
selected and were measured using Zen10 software (Carl Zeiss Microscopy, Oberkochen), (see 
randomisation protocol in Appendix K). The surface area of each chosen corpuscle was measured 
following methods adapted from Sedeek et al (2013). The surface area (µm2) of the glomerular 
corpuscle and the glomeruli were measured by tracing around the perimeter of the glomerular 
corpuscle and glomeruli. From these measurements, the diameter (µm) and perimeter (µm) of the 
corpuscle and glomeruli was generated using the Zen software. The surface area (µm2) of the renal 
space was quantified according to Equation 4.1. Finally, the outer surface area (OSA) and luminal 
surface areas (LSA) of three of the nearest proximal convoluted tubules (PCTs) to the glomerular 
corpuscle were measured (Figure 4.3). Both the diameter (µm) and perimeter (µm) of these areas 
were generated on the Zen software. To quantify tubular wall thickness in the PCTs, the difference 
of the OSA and LSA was found (Equation 4.2).  
 
Stain Definition Score 
Gordon and Sweet’s Reticulin stain  Measuring architectural changes in reticulin fibres 
• Normal  
• Slight disruption to architecture 
• Moderate disruption to architecture 
• Severe disruption to architecture 
 
0 
1 
2 
3 
Periodic Acid Schiff Stain Measuring glycogen deposits based on staining intensity 
• Normal  
• Slight glycogen deposits 
• Moderate glycogen deposits 
• Severe glycogen deposits 
 
0 
1 
2 
3 
Masson’s Trichrome Measuring fibrotic changes 
• Normal 
• Slight fibrotic lesions 
• Moderate fibrotic lesions 
• Severe fibrotic lesion 
 
0 
1 
2 
3 
Stellenbosch University  https://scholar.sun.ac.za
46 
 
 
 
Equation 4.1: Equation demonstrating the surface are in (µm2) of the Bowman’s space. 
 
 
Equation 4.2: Quantifying tubular wall area (µm2). 
 
 
Figure 4.3: Morphometric measurement of the glomerular corpuscle and proximal convoluted tubules. 
The highlighted regions demonstrate the site of the surface area measurements of; A) glomerular corpuscles 
(µm2) (red) and glomerular surface areas in µm2 (green); B) The proximal convoluted tubules outer surface 
area in µm2 (yellow) and inner surface area in µm2 (blue) (100x magnification) Bar=100 µm. 
 
4.8 PATHOLOGICAL SCORING OF THE PANCREAS, LIVER, AND KIDNEY 
Each slide was thoroughly assessed for pathology and variations in cellular components. Each organ 
system was analysed using semi-quantitative methods of grading and scoring specifically looking at 
early manifestations of cellular damage. Study participants were blinded to the groups analysed. 
Three individuals, including two histologists scored the tissue. A veterinary histopathologist Dr E.C. 
Du Plessis (IDEXX laboratories, Ondersteport campus, Faculty of Veterinary Science, University of 
Pretoria) was consulted for the confirmation of findings.  
 
RS = GCSA-GSA 
RS: Renal space 
BCSA: Glomerular corpuscle Surface Area (µm2) 
GSA: Glomerular Surface Area (µm2) 
Tubule wall area = OSA-LSA 
OSA: Outer Surface area (µm2) 
LSA: Luminal Surface Area (µm2) 
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Whole tissue sections were analysed for early manifestations of cellular damage and scored (Table 
4.2). These early manifestations of cellular damage were defined as follows: Cellular swelling or 
granular cytoplasm is defined by a “cloudy” or “ground glass” appearance in the cytoplasm of the 
cell. Hydropic degenerations are referred to as “vacuolar degeneration”, is the appearance of vacuoles 
within the cell; as membrane permeability decreases, water accumulations increase, producing clear 
vacuoles within the cell. Fatty changes are characterised by the accumulation of fat deposits within 
parenchymal cell providing a “foamy” appearance. The nucleus in this instance is not displaced 
within the cells. Severe cases of lipid accumulations cause large fat vacuoles to appear distending the 
cell and compressing the nucleus against the cell membrane. Advanced stages of fatty change will 
cause cells to rupture into large fatty cyst. Inflammatory foci was described as the presence of 
lymphocytes that were dispersed randomly throughout the tissue or localised is specific areas. 
 
  
Stellenbosch University  https://scholar.sun.ac.za
48 
 
 
Table 4.2: The semi-quantitative methods of grading and scoring including identifying pathological 
features. 
 
 
4.9 POLYPHENOL CHARACTERISATION 
A short experiment was conducted to determine the effects of temperature and time on the polyphenol 
content of the 2% rooibos tea solution. This was conducted to determine whether the concentration 
of polyphenols given to rats was consistent throughout the week. Each series followed a time pattern 
in which it was prepared and exposed to the same room conditions as the rat cohorts. Thus, the tea 
samples would mimic the amount of time rats were exposed to the same tea solution in a specific 
environment.  
 
Three litres of the tea were made up following the methods described in Section 4.4, and divided into 
three series of 500 mL each. Series 1 (S1-Fresh) consisted of freshly made tea, series 2 (S2-Fridge) 
was refrigerated at 4 °C for one week and series 3 (S3-Frozen) consisted of tea that was stored in a 
freezer (-20 °C) for two weeks. All tea groups were stored in light limiting bottles.  
 
Each series was then further divided into two sub-groups day 1 (D1) and day 7 (D7) of 300 mL each 
respectively (Figure 4.4). The D1 sub-groups were immediately freeze dried after the specified 
storage times for each series (Appendix L). The D7 groups were placed at room temperature 
following 12-hour light and dark cycles at 40% humidity in light limiting bottles wrapped in 
aluminium foil for a period of one week. The bottles mimicked the same procedures as given to the 
animal cohorts. Each tea series (150 mL) was subsequently frozen with liquid nitrogen in virtis 
Organ  Score Scoring system 
Pancreas P0 
P1 
P2 
P3 
P4 
normal, 0% of tissue is affected 
slight, <5% of tissue is affected 
mild 5%-20% of tissue is affected 
moderate, 20%-60% of tissue is affected 
severe, >60% of tissue is affected 
Liver L0 
L1 
L2 
L3 
L4 
normal, 0% of tissue is affected 
slight, <5% of tissue is affected 
mild 5%-20% of tissue is affected 
moderate, 20%-60% of tissue is affected 
severe, >60% of tissue is affected 
Kidney K0 
K1 
K2 
K3 
K4 
normal, 0% of tissue is affected 
slight, <5% of tissue is affected 
mild 5%-20% of tissue is affected 
moderate, 20%-60% of tissue is affected 
severe, >60% of tissue is affected 
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cryogenic flasks and lyophilized using a Labcoco™ (Vacutec, Roseveld park, South Africa) freeze 
dryer for 24 to 48 hours, or until completely freeze dried. Freeze dried samples were stored at room 
temperature in airtight plastic containers, covered in aluminium foil and placed in a dark dry cupboard 
until all samples were completed. Samples were sent for polyphenol characterization using liquid 
chromatography-mass spectrometry (LC-MS) techniques. 
 
 
Figure 4.4: Rooibos tea allocation. Day 1 samples followed the specifies storage times and were immediately 
freeze-dried, groups marked day 7 (yellow) were kept at room temperature following 12-hour light and dark 
cycles, at 40% humidity, to mimic the condition the rats were exposed to during experimentation. The green 
arrow demonstrates the time sequence in days from the making of the tea until freeze drying. 
 
Polyphenolic characterisation was conducted at the Central Analytical Facility (CAF) at Stellenbosch 
University per their standardised methods. Liquid chromatography-mass spectrometry analysis was 
conducted using a Waters Synapt G2 quadrupole time-of-flight mass spectrometer. The spectrometer 
was fitted with a Waters ultra-pressure liquid chromatograph and photo diode array detection. 
Polyphenol separation was attained using a Waters HSS T3, 2.1x150 mm column with 1.7 µm 
particles. A 0.1% formic acid (solvent A) and acetonitrile containing 0.1% formic acid (solvent B) 
gradient was applied. A linear gradient was exercised starting at 100% using solvent A for one minute 
and was then changed to solvent B for 22 minutes. Once complete, the gradient was changed, where 
40% of solvent B was used for 50 seconds. A wash step was conducted for one and a half minutes at 
100% of solvent B. Following this, re-equilibration to initial conditions was applied for 4 minutes. A 
flow rate was established at 0.3 mL/min, the column was kept at 55 ºC. An injection volume of 1 µL 
was used.  
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Data was captured in MSE mode which consisted of a low collision energy scan of 6 V from m/z 150 
to 1500 and a high collision energy scan from m/z 40 to 1500. The high collision energy scan was 
done using a collision energy ramp of 30-60 V. The photo diode array detector was set to scan from 
220-500 nm. 
 
The mass spectrometer sensitivity was optimized at a cone voltage of 15 V. Nitrogen was used as the 
desolvation gas at a rate of 650 l/hr at a temperature of 275 °C. The instrument ran with an 
electrospray ionization probe in the negative mode. The negative mode is used to identify negatively 
charged compounds like polyphenols. Calibration was established using sodium formate. Leucine 
encephaline was infused in the background as a lock mass for accurate mass determination. 
 
4.10 STATISTICAL ANALYSIS 
For statistical analysis, a biostatistician, Professor Martin Kidd at the Centre for Statistical 
Consultation, Department of Statistics and Actuarial Sciences, Stellenbosch University, was 
consulted for quantitative and descriptive statistics. Statistical analysis was conducted with the 
Statistica® version 13.2 (Dell, 2014, USA) software. The raw data is plotted against a theoretical 
normal (linear graph) which differentiated outliers that may have influenced statistical significance.  
 
Descriptive statistics were performed for all data collected; mean values, standard deviations and 
standard errors were obtained. From this data, graphs were constructed to visually represent the data 
at a confidence interval of 95%.  
 
An analysis of variance (ANOVA) was conducted. This is a statistical technique used to determine 
the variance of normally distributed independent samples. This technique is used to test variations in 
sample groups by assuming each sample group is equal to the other (null hypothesis). A significant 
difference is found when the null hypothesis is rejected at p-value ≤ 0.05. Lavene’s test was used to 
determine the homogeneity of variance between samples by assuming the variance is equal across 
groups.  
 
Fischer’s Least Significant Difference (LSD) post hoc test was additionally conducted. The LSD is a 
test to identify which means are significant. Additionally, this test provides an indication of trends 
between two variables. A trend was defined at a LSD<0.05. 
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The following section will provide graphical, statistical and descriptive evidence on the effects of 
ART and rooibos on the pancreas, liver, and kidney. A section reporting on pathology and additional 
findings is given. Using ANOVA, statistical significance was determined at a p-value less than 0.05. 
Trends were reported at an LSD value less than 0.05.  
 
5.1 DESCRIPTIVE AND STATISTICAL ANALYSIS ON BODY MASS 
No changes in body mass were observed between the treatment groups; however, a trend was 
observed where the C-R had a higher body mass (Table 5.1) compared to the other treatment groups 
(LSD= 0.032). 
 
Table 5.1: Number of samples (n-value), and mean body mass (g) between the different groups (± Std. 
Dev). 
Group n-value Mean body mass (g) 
C 10 277.10±37.09 
C-ART 10 284.70±26.07 
C-R 10 307.10±32.02* 
ART+R 10 284.00±32.02 
* Indicates a trend observed with an LSD < 0.05. Control (C); Control antiretroviral therapy (C-ART); Control 
rooibos (C-R), Experimental (ART+R). 
 
5.2 THE EFFECTS OF TREATMENT ON PANCREATIC ISLETS 
The number of pancreatic islets, as well as morphometric measurements on islet area including α and 
β-cell areas were determined, to investigate the effects of treatment on islet architecture. Using 
absolute values, pancreatic islet size (measured in µm2) did not vary significantly between groups 
(Figure 5.1 A). No differences were found between the number of islets per section area (total size of 
tissue measured) (Figure 5.1 B). When α-cell area was expressed as a percentage of the mean islet 
area (Figure 5.2 A), the LSD post hoc test demonstrated a trend where the ART+R group had a smaller 
percentage of α-cells compared to the C-R group (LSD =0.028). However, these groups did not vary 
from the control.When β-cell area was expressed as a percentage of the mean islet area (Figure 5.2 
B), a signifcant difference was found where the ART+R group had a larger percentage of β-cells 
compared to the C-ART and C-R group. Yet, neither group varied from the control. Absolute values 
and decriptive statistics for all measurements can be found in Appendix M. 
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Figure 5.1: Effects of treatment on pancreatic islet size and number. A) Mean pancreatic islet size across 
groups (um2) did not vary significantly (p=0.41); B) Mean number of islets per section area did not vary 
significantly (p=0.67). Vertical bars denote standard errors of the mean. Control (C); Control antiretroviral 
therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
 
 
Figure 5.2: Effects of treatment on the percentage of α- and β-cells areas. A) Percentage of α-cells to mean 
islet area did not vary significantly between groups (p=0.15), a trend (LSD=0.027) was found where the C-R 
had a higher α-cell area to total islet area compared to the ART+R group; B) Percentage of β-cells varied 
significantly between groups (p=0.01) where the ART+R had a significantly greater percentage of β-cells 
compared to the C-ART and C-R groups. No group varied significantly from the C group. Vertical bars denote 
standard errors of the mean. Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), 
Experimental (ART+R). 
 
5.3 THE EFFECTS OF TREATMENT ON THE LIVER 
The aspartate aminotransferase (AST) and alanine aminotransferase (ALT) serum biomarkers did not 
differ significantly between groups (ALT; p=0.98; AST; p=0.89; AST:ALT; p=0.92), indicating that 
neither ART nor rooibos caused major changes to liver function compared to the control (Figure 5.3). 
All absolute values and LSD post hoc values are presented in Appendix M. 
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Figure 5.3: Effects of treatment on liver function biomarkers. A) Aspartate aminotransferase values were 
not significantly different between groups (p=0.89). B) Alanine aminotransferase levels were not significant 
between groups (p=0.98). C) The AST: ALT ratio which indicates liver function, were not significant between 
groups (p=0.92). Vertical bars denote standard errors of the mean. Control (C); Control antiretroviral therapy 
(C-ART); Control rooibos (C-R), Experimental (ART+R). 
 
5.4 THE EFFECTS OF TREATMENT ON THE KIDNEY  
Surface area measurements of the corpuscle were made by measuring around the perimeter of the 
Bowman’s capsule. A trend was present between the C-R group and ART+R group, where the 
glomerular corpuscle tended to be larger in the C-R group (LSD=0.017). This was consistent with the 
diameter measurements (LSD=0.029) (Figure 5.4 A, B). Despite this, the size of the corpuscle was 
not significantly different to the control. The surface area and diameter of the glomerulus did not vary 
significantly between groups (Figure 5.4 C, D) Absolute values and LSD post hoc values are 
presented in Appendix M. 
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Figure 5.4: Effects of treatment on the size of the glomerular corpuscle and glomeruli. A) The surface 
area (p=0.11); B) and diameter (p=0.17) did not vary significantly between groups, however, trends were 
observed between the C-R and ART+R groups (LSD=0.017 and LSD=0.029) respectively. There was no 
statistical significance present in; C) the glomerular surface area (p=0.26) and; D) glomerular diameter 
(p=0.36). Vertical bars denote standard errors of the mean. Control (C); Control antiretroviral therapy (C-
ART); Control rooibos (C-R), Experimental (ART+R). 
 
The size of the renal space was determined by finding the difference between the corpuscle and 
glomerular surface area. Trends were observed between the ART+ R and both C-ART (LSD=0.034) 
and C-R (LSD=0.029) groups. The ART+R group tended to have a smaller renal space, area 
compared to the C-R group. However, these were not significantly different from the control (Table 
5.2). A similar trend was observed between the C-ART and ART+R groups where the renal space 
width was smaller in the ART+R group (LSD =0.036). Although, these changes were not statistically 
significant different from the control. Absolute values and LSD post hoc values are detailed in 
Appendix M. 
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Table 5.2: The space and width of the renal space (± Std. Dev). 
Treatment group Size of the renal space (µm2) Renal space width (µm) 
C 2507.42±284.83 18.20±1.89 
C-ART 2747.18±637.98* 19.90±3.49* 
C-R 2763.14±680.75* 19.25±3.49 
ART+R 2212.90±473.95* 19.25±4.51* 
* Indicates trend in the groups. Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), 
Experimental (ART+R). 
 
The size of the proximal convoluted tubules (PCT) were determined by measuring the outer surface 
area (OSA) and luminal surface area (LSA). The size of the tubule wall was determined by finding 
the difference between the OSA and LSA. Table 5.3 details the area and diameter of the OSA and 
LSA, as well as tubule wall area and wall thickness for all groups. Statistical significance was 
observed in the luminal surface area and diameters between the C-R and ART+R groups. This 
significance shows that the C-R groups had the largest luminal surface area and diameter, while the 
ART+R had the smallest. Neither the C-R nor the ART+R groups were significantly different from 
the control. In general, the PCT of the C-R group were larger compared to the other groups. However, 
the tubular wall thickness was consistent throughout the groups, thus the size of the tubule remained 
constant compared to the control.  
  
Table 5.3: The average surface area and diameter of the proximal convoluted tubules of antiretroviral 
therapy and rooibos treated rats (±Std. Dev). 
 C C-ART C-R ART+R 
Outer surface     
 Area (µm2) 2359.41±256.41 2403.60±494.60 2528.53±293.21 2276.37±397.49 
 Diameter (µm2) 53.57±4.33 54.03±2.79 55.37±5.34 53.11±3.09 
Luminal surface     
 Area (µm2) 586.73±192.28ab 592.53±125.01ab 734.65±245.04a 496.75±173.62b 
 Diameter (µm2) 25.73±2.73ab 25.79±5.07ab 28.92±3.61a 23.90 ±3.61b 
Tubule wall     
 Area (µm2) 1772.67±236.20 1811.07±264.72 1793.89±199.31 1779.62±292.08 
 Diameter (µm2) 27.85±3.28 28.24±1.41 28.24±2.67 29.20±3.14 
Differing letters indicate significant differences. Groups sharing letters do not indicate statistical significance. 
Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
 
5.5 PATHOLOGY  
5.5.1 Scoring of the pancreas 
No pathological lesions nor subtle morphological changes, such as granular cytoplasm, vacuolations, 
fatty changes or inflammatory foci were observed. The arrangement of α- and β-cells, as seen through 
immunohistochemistry, correspond to what has been classically described. The β-cells labelled 
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pink/red were centralised forming the bulk of the islet and were surrounded by the α-cells, labelled 
brown with anti-glucagon antibody at the periphery (Figure 5.5). This pattern was followed in each 
treatment group and did not vary from the control. Thus, pancreatic islet morphology was maintained 
with no instances of subtle changes between groups. A summary of all observations is presented in 
Appendix M. 
 
Figure 5.5: Pancreatic islet micrographs showing islet histomorphology in the various groups. H&E 
stained and immunohistochemistry labelled pancreatic islets of A) control (200 x magnification); B) C-ART 
C) C-R and D) ART+R animal. No major changes were observed in the labelled islets. (100 x magnification), 
bar= 20 µm. 
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Instances of lymph nodes with active centres were observed (Figure 5.6). The lymph nodes were 
mildly active and were found in the paracortical regions of the pancreatic acinus, one in the control 
group, two in the C-ART and C-R group, and three in the ART+R group. The inclusions of the lymph 
nodes were incidental, the activity of the nodes was mild and not considered a lesion. Thus, the 
pancreas was scored normal for each group. 
 
 
Figure 5.6: Haematoxylin and eosin stained pancreatic lymph node. Black arrows show the mildly active 
centres at the paracortical region of the lymph node (50 x magnification) Bar=100 µm. 
 
5.5.2 Scoring of the liver 
Detailed pathological examination of H&E stained slides demonstrated that the liver was consistent 
in all groups to what is classically described. Subtle histological changes were observed in all groups, 
including granular cytoplasmic changes (Figure 5.7), vacuolations (Figure 5.8), and inflammatory 
foci (Figure 5.9). Of the total sample, 44% had granular cytoplasmic changes, consisting of 8% from 
the C group, 13% from C-ART, 15% from C-R, and 10% from ART+R. The most predominant 
histological change observed was vacuolation with 64% of the sample affected, where the C-ART 
group constituted 20% of the total. Inflammatory foci were rarely observed affecting only 13% of the 
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total sample of which the C-ART group contributed 8%. It should be noted that these were scored a 
level 1 indicating the subtleness of the change. 
 
 
Figure 5.7: Occurrence of granular cytoplasm in the treatment groups. The percentages indicate the 
presence of granular changes across groups. Each percentage was calculated from the total sample size. The 
cumulative percentage is indicated. The total 44% affected was distributed as follows; 8% C, 13% C-ART, 
15% C-R, and 10% ART+R. Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), 
Experimental (ART+R).  
C-ART 
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Figure 5.8: Occurrence of vacuolation in the treatment groups. The percentages indicate the presence of 
vacuolation across groups. Each percentage was calculated from the total sample size (N=40). The cumulative 
percentage is indicated. Of the total 64%, 13% of the C group was affected followed by, 20% in the C-ART, 
13% in the C-R and 18% in the ART+R groups. Control (C); Control antiretroviral therapy (C-ART); Control 
rooibos (C-R), Experimental (ART+R). 
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Figure 5.9: Occurrence of inflammatory foci in the treatment groups. The percentages indicate the 
presence of inflammatory foci across groups. Each percentage was calculated from the total sample size 
(N=40). The cumulative percentage is indicated. Of the total 13% affected, 5% was derived from the C 
followed by, 8% in the C-ART, the C-R, and ART-R were unaffected. Control (C); Control antiretroviral 
therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
 
Granular cytoplasmic changes and vacuolations in liver hepatocytes were present in all groups 
including the control (Figure 5.10). These changes were localised around the central vein and 
periportal regions, however these changes were mostly diffuse. The presence of inflammatory foci 
was observed in the liver parenchyma and were confined to two groups, namely the C and C-ART. 
The presence of these inflammatory foci is, however, negligible as the presence was too insignificant 
to indicate inflammation and was scored a level 1 (Figure 5.11 A, B). 
C-ART 
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Figure 5.10: Photomicrographs depicting liver histology in a control animal. A) H&E stained (50 x 
magnification) slide of a hepatic lobule showing a central vein surrounded by portal tracts. Black arrows denote 
slight vacuolation around the central vein; B) Reticulin stained micrograph (100 x magnification) 
demonstrating liver architecture; hepatocytes are lined by a continuous network of black reticulin fibres (red 
arrows); C) PAS stained central veins (100 x magnification) with black arrows showing glycogen dense 
hepatocytes; D) Masson’s Trichrome (MT) stained portal tract (100 x magnification) showing the light blue 
stained collagen fibres (black arrows). Bar=20 µm. CV=Central vein, PT=Portal tract, HA=Hepatic artery, 
PV=Portal vein, BD=Bile duct, CAP=Capsule. 
 
Analysis of the reticulin stain revealed slight disruptions in reticulin fibres, around central veins, 
towards the capsule or areas where granular and vacuolar changes were present (Figure 5.11 C, D). 
These disruptions were very mild and the liver was scored as normal. No instances of pathological 
glycogen accumulations were found in PAS stained livers and these were scored as normal (Figure 
5.11 E). No major accumulation of collagen fibres indicative of fibrosis was observed using the MT 
stain (Figure 5.11 F). Overall, normal liver morphology was maintained. A summary of all 
observations is presented in Appendix M. 
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Figure 5.11: Photomicrographs of subtle tissue changes in the liver. A) H&E stained central vein showing 
slight vacuolation in the liver (100x magnification); B) H&E stained hepatic lobule showing inflammatory 
foci (black arrows) (100x magnification); C & D) Reticulin stained liver showing slight disruption of reticulin 
fibres around the central vein where vacuolation occurred (black arrow) (100x magnification); E) PAS stained 
portal tract showing glycogen rich hepatocytes (black arrow) (100x magnification); F) MT stained liver 
showing collagen fibres (black arrow) (100x magnification) were maintained. CV=Central vein, PV= Portal 
vein, HA= Hepatic artery, BD= Bile duct. Bars= 20 µm. 
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5.5.3 Scoring of the kidney 
Detailed pathological examination using H&E sides showed no instances of kidney lesions, which 
would have been indicative of nephrotoxicity (Figure 5.12 A). Granular cytoplasmic changes were 
not observed, however vacuolations were observed in the proximal convoluted tubules (PCT) in all 
groups. The presence of vacuolations were so slight and random that they were not quantifiable and 
the kidney was scored as normal (Figure 5.12 B). Slight instances of proteinaceous material (Figure 
5.12 C) were found throughout the kidney, specifically in the proximal convoluted tubules and 
medullary region, however did not indicate pathology. Examination of PAS stained slides 
demonstrated no indication of basement membrane thickening within the glomerulus. These findings 
correlate to the lack of changes observed in the glomerular corpuscle and PCT when measured. A 
summary of all observations is presented in Appendix M. 
 
 
Figure 5.12: Photomicrographs (200 x magnification) of the rat kidney. A) H&E stained glomerular 
corpuscle of a control animal showing normal glomerular structure; B) PAS stained glomerular corpuscle 
showing the slight vacuolation (black arrow) in the proximal convoluted tubules; C) H&E stained kidney 
showing proteinaceous material in the proximal convoluted tubules (black arrow). Bars= 20 µm. PCT= 
proximal convoluted tubules, DCT=Distal convoluted tubules, GLOM=Glomerulus, RS=Renal space, 
BC=Bowman’s capsule.  
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5.6 ROOIBOS TEA STANDARDS 
The quantity of polyphenols remained constant throughout all groups (Figure 5.13 A, B, C). However, 
some changes were observed between the Day 1 and Day 7 samples in each group. Aspalathin, the 
most abundant rooibos polyphenol, had one of the highest peaks (449, 451) in all groups. Quercetin-
3-O-robinobioside/rutin (609), orientin (447) and iso-orientin (447) showed some decreases within 
groups. However, when superimposed (Figure 5.13 D), no major observable differences were found 
in aspalathin concentrations (449, 451) in the refrigerated and frozen samples when compared to the 
control fresh sample. The results indicate that rooibos tea can be stored for a period of four weeks 
refrigerated or frozen at -4 °C without drastic changes in rooibos polyphenol concentrations, 
indicating that the rats received similar concentrations of rooibos polyphenols throughout the week. 
Singular chromatograms of each group are provided in Appendix M. 
 
 
Figure 5.13: Rooibos chromatograms showing the amount of rooibos polyphenols. A) Day 1 and day 7 
fresh; B) Day 1 and day 7 refrigerated; C) Day 1 and Day 7 frozen; D) super imposed image of all groups 1, 
2= 449 (Aspalathin found in fermented samples), 3= 447 (Orientin and iso-orientin), 4= 451 (Aspalathin in 
fermented and unfermented samples), 5= 609 (Qurcetin-3-O-glucoside), 6= 431 (Apigenin-8-C-glucoside) 7a= 
435 (Nothofagin), 7b= 469 (unknown substance), 8= 301 (Quercetin found in fermented rooibos samples) 9*= 
Unknown substance. Flow rate=0.3 µl/min, column=Waters HSST3, 201x150 nm, column temperature=55 
°C, detection wavelength=220-500 nm, injection volume= 1 µl.  
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Antiretroviral drugs are widely-used and administered specifically for the treatment of human 
immunodeficiency virus (HIV) (Herlitz et al., 2010; Meintjes et al., 2017). The severity of the 
epidemic has led to accelerated licencing of many antiretroviral drugs without considering the 
potential risks of long term treatment (Carr & Cooper, 2000). Increasing reports of antiretroviral 
adverse drug reactions (ADRs) in affected individuals is concerning, often resulting in the 
discontinuation of treatment (Monforte et al., 1999; Ammassari et al., 2001; Carr, 2003). Numerous 
studies have reviewed the overall adverse effects of antiretroviral drugs, yet, most ADRs were 
reported in HIV-positive individuals or individuals receiving alternate drug combinations to the one 
used in the current study (Brinkman et al., 1998; Fellay et al., 2001; Rudorf & Krikorian, 2005; Carr 
& Cooper, 2010; Jao & Wyatt, 2010; Neuman et al., 2013).  Human immunodeficiency virus causes 
several adverse reactions in the body such as HIV associated nephropathy (HIVAN) (Winston et al., 
1998). Other adverse reactions, as a result of HIV, may be due to immune compromise, leading to 
the manifestation of opportunistic infections. Lee et al (1993) showed that HIV-infected individuals 
are especially prone to ADRs as a consequence of HIV altering the metabolism of oxidative pathways, 
which could potentially be worsened with the introduction of ART (Styrt et al., 1996). The present 
study had the opportunity to investigate the effects of a specific ART combination, commonly used 
in South Africa, on the histomorphology of the pancreas, liver, and kidney in a HIV-negative rat 
model. The study simultaneously introduced a 2% weight over volume (w/v) fermented rooibos tea 
solution to determine whether the histologically observable effects of ART could be attenuated. In an 
effort to curb the number of animals used in research, the current study used tissue from rats obtained 
from the Medical Physiology Department of Stellenbosch University, in a study that observed the 
physiological effects of a 2% rooibos tea solution on the hearts and aortas of antiretroviral treated 
male Wistar rats (Imperial, 2017). Reference is made to the results found in that study to support the 
findings here. 
 
Numerous studies (Carr et al., 2000, Guzik et al., 2006; Lagathu et al., 2007; Stein et al., 2007; 
Lugassy et al., 2010) have been published on the metabolic effects of ART. The exact mechanism of 
weight gain caused by ART is a multifactorial process and may be correlated to the reversal of HIV 
associated wasting (Dorey‐Stein et al., 2008) and adipocyte dysfunction (Carr et al., 1998). The lack 
of significant changes in body weight in the C-ART group, in this study, agrees with current literature, 
where no significant body mass gain was observed in patients receiving a daily dose of Efavirenz 
(FTC), Emtricitabine (EMT), Tenofovir (TDF) (Deeks & Perry, 2010). The lack of a significant 
weight reduction in the C-ART group in the current study could be dose dependant, as significant 
body weight reductions were observed by Lebrecht et al (2009) in rats given a dose of 100 mg/kg/day 
of TDF for 8 weeks. Additionally, weight gain is primarily associated with the use of the nucleoside 
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reverse transcriptase inhibitors (NRTIs) namely, stavudine, zidovudine and protease inhibitors (PIs) 
(Martinez et al., 2001). The drug combination used in the current study does not contain PIs or the 
NRTIs mentioned by Martinez et al (2001), thus, significant weight loss or weight gain was not 
expected and confirmed by the results of this study. Though fluid consumption remained constant 
between groups (Imperial, 2017), rooibos tended to increase the body weights of the rats, although 
these were not significantly different from the control groups. Rooibos has been reported to improve 
appetite (Morton, 1983) which could have resulted in the slightly elevated body weights observed. 
Food consumption in the present study was not measured, thus the slight increase in body weight 
cannot be confirmed as a change in appetite alone. The fact that these changes were not significant 
agrees with the current literature given that rats fed fermented (Baba et al., 2009) and unfermented 
(Ajuwon et al., 2013) rooibos tea infusions did not gain weight. 
 
The current study is operating under the premise that antiretroviral drugs are causing oxidative stress 
(Jian et al., 2007) leading to histological observable changes. The lack of significant findings in the 
pancreas, liver, and kidney suggest that the FTC, EMT, and TDF combination is relatively safe in 
HIV-negative rodents. Thiobarbituric acid reactive substances (TBARS) is a common analytical test 
used to measure lipid peroxidation, thereby providing a measure for oxidative stress (Janero, 1990). 
Ideally, an increase in TBARS was expected to be observed in the C-ART group with a subsequent 
decrease to control levels in the ART+R group. However, no significant differences, indicated by the 
following values (C=7.69±0.55; C-R=7.49±0.39; C-ART=7.54±0.79; ART+R=5.39±0.53 µmol/L), 
were observed between groups in the animals used in the current study, conducted by Imperial (2017). 
The absence of a potent oxidative stressor to induce a change could suggest the lack of histologically 
observable differences in the current study.  
 
Both the exocrine and endocrine portions of the pancreas have been reported to be affected with the 
use of ART, including pancreatic acinar atrophy, and increases in islet size and volume, respectively 
(Chehter et al., 2000; Neuman et al., 2012; Barbosa et al., 2013; Ferreira et al., 2015). No major 
histological changes such as acinar atrophy, indicating exocrine pancreatic damage, was observed in 
the current study. The size of pancreatic islets and the number of pancreatic islets per section area did 
not vary in the present study. This could be due to the size of the tissue section, as size could have 
led to increases in the number of islets measured between groups. Since tissue was taken from the 
gastrosplenic portion of the pancreas, the area in which the sample was taken could have further 
influenced results, as size and number of islets are greater in this area of the rat pancreas (Elayat et 
al., 1995). Barbosa et al (2013) and Ferreira et al (2015) have correlated ART to enlarged islets. Both 
studies associated these changes to long-term use of ART. The lack of significant changes in islet 
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size in the current study suggests that the experimental period was not sufficient to cause a change. 
This is further supported by the lack of changes in the percentage of α and β-cells compared to the 
control group. 
 
There is an increased incidence of diabetes in HIV-positive individuals receiving ART (Carr et al., 
1998; Brown et al., 2005). In the pancreas, diabetes is associated with changes in islet size (Froulob 
et al., 2010), number (Taniyama et al., 1999), increased β-cell dysfunction, and decreased β-cell 
volumes (Michels et al., 1986). Pancreatic β-cells contain very low levels of cellular antioxidants 
(Sakuraba et al., 2002), resulting in a reduction in β-cell function due to oxidative stress. The current 
study did not observe a change in percentage of α-or β-cells compared to the control group. Further 
illustrating the failure of ART, in the present study, to cause significant oxidative stress to lead to 
changes in β-cell size, number, and distribution. To our knowledge, no study has reported on the 
changes in α-and β-cells with the EMT, TDF, FTC combination. This could be due, firstly, to the 
relative safety of this combination as adverse events leading to discontinuation are seldom with the 
EMT, TDF, FTC combination (Zolopa et al., 2013). Secondly, antiretrovirals are not causing 
significant amounts of oxidative stress to induce a change in the number of α and β-cells in this HIV- 
negative rat model. Lastly, the lack of a viral load or the duration of treatment was not sufficient to 
warrant a change in the current study. Other factors such as dietary and lifestyle differences could 
account for the increased incidence of diabetes in HIV-infected individuals receiving ART, since 
reports of diabetic complications were prevalent among HIV-infected individuals before the 
introduction of ART (Hadigan & Grinspoon, 2008). Other studies have directly associated insulin 
resistance and concomitantly diabetes, to the actions of PIs (Brown et al., 2005), concluding that 
these drugs inhibit the actions of glucose transporter 4 (GLUT-4). Moreover, pancreatic involvement 
could be directly linked to the actions of HIV itself (Chehter et al., 2000). Therefore, the lack of 
significant results could be due to the absence of external variables that would otherwise lead to 
significant changes to pancreatic islet histomorphometry in HIV-postive humans. 
 
The lack of changes in the C-R group was expected, as rooibos has shown to attenuate instances of 
oxidative stress (Francisco, 2010; Awoniyi et al., 2012; Chen et al., 2013) in diabetic complications 
(Ulcina et al., 2006; Francisco, 2010; Muller et al., 2012) by improving β-cell function (Son et al., 
2013; Kamakura et al., 2015) and overall oxidative status (Marnewick et al., 2003). A common 
feature of these studies is that an oxidative stressor was induced, either by the introduction of 
streptozotocin (STZ) (Ulcina et al., 2006) or  a high fat diet (Mathijs et al., 2014), to observe the 
potential therapeutic effect of the antioxidant agent. β-cell vacuolation has been observed in diabetic 
rat models with the simultaneous restoration of β-cells with added polyphenols (Adewole et al., 
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2007). This was further observed by Chellan et al (2014), where the introduction of an unfermented 
version of honeybush tea increased β-cell proliferation in STZ diabetic rats, comparable to the actions 
of the antidiabetic drug, metformin. The same study concluded that β-cell protection was due to the 
actions of the antioxidants (magiferin, isomangiferan and xanthose) present in honeybush (Chellan et 
al., 2014). Kajimoto and Kaneto (2004) further noted that in oxidative conditions, β-cell mass 
significantly increased when mice were treated with antioxidants. No instances of β-cell vacuolations 
were observed in the present study with either ART or rooibos administration. Rooibos polyphenols 
in the current study did not show attenuating effects in pancreatic β-cells comparable to those 
observed in other studies (Kajimoto & Kaneto, 2004; Adewole et al., 2007, Chellan et al., 2014). 
This may be due to the fact that ART, in the current study, did not cause major oxidative stress to 
warrant a significant histomorphological change to pancreatic α- and β-cells. Similarly, rooibos could 
not demonstrate an attenuating effect as no oxidative stress was induced correlating to the lack of 
changes observed in the experimental group compared to the control. Overall, islet histomorphometry 
remained constant in the present study. 
 
The likelihood of these changes to be expressed in other organs is slight; however, as drugs are 
metabolised and excreted by target enzymes in the liver and kidney, their effects may be more evident 
in these areas. Severe liver dysfunction is defined as a grade five times greater than baseline (Soriano 
et al., 2008). In rats, baseline is recorded at ALT: 17.5-30.2 µ/L and AST: 45.7-80.8 µ/L (Thapa & 
Walia, 2007). Elevations in liver transaminases are associated with the use of ART (Núñez, 2006). 
Aspartate aminotransferase and ALT serum levels in the current study, were only slightly elevated 
above baseline; however, these were not significantly different compared to the control group. The 
present study did not find any significant changes in the liver indicative of hepatotoxicity. These liver 
function tests are the most common diagnostic feature for liver function (Amacher, 1998; Ozer et al., 
2008). Both AST and ALT have specificity outside the liver and may specify instances of damaged 
myocytes (Ozer et al., 2008). 
 
The ratio of AST:ALT provides a better indication of liver function (Ozer et al., 2008). The ratio of 
liver transaminases in the present study indicates that no major liver alterations occurred. Liver 
enzyme elevations have been reported with the use of all ARTs (Wit et al., 2002; Núñez, 2006) with 
neverapine (Sanne et al., 2005; Neuman et al., 2012) and PIs, being the greatest offenders often 
leading to hepatotoxicity in HIV-infected individuals receiving cART. In clinical settings, liver 
enzyme elevations need to be critically analysed as a significant proportion of elevations may be due 
to hepatitis B infection flares, and not necessarily the actions of ART (Soriano et al., 2008). It should 
be noted that liver enzyme elevations are not the sole indicator of liver toxicity. In clinical trials, liver 
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enzyme elevations are often accompanied and confirmed histologically by the presence of 
hepatotoxic lesions (Amacher, 1998). No histopathological lesions in the present study was observed 
that were indicative of hepatotoxicity, corresponding to the lack of liver enzyme elevations. 
Zimmerman (1999) stated that hepatotoxicity may present as necro-inflammatory changes similar to 
that observed in chronic viral hepatitis. Additionally, major distortion to liver architecture, 
specifically the collapse of the reticulin network and enlargement of hepatocyte may occur with the 
use of ART (Neuman et al., 2012). Instances of necrosis and severe congestion of the portal and 
venous system have additionally been reported with the use of ART (Adaramoye et al., 2012). The 
specialised stains, specifically the reticulin stain, used in the present study, would single out more 
subtle changes that would be difficult to see on standard H&E stained tissue. No major distortion to 
the reticulin network of the liver was observed in the current study which would indicate ART 
induced hepatoxicity, although very subtle histological changes, including granular cytoplasm and 
vacuolations were present. The incidence of these changes within the liver are normal and often 
reversible (Robins & Angell, 1976; Wit et al., 2002), however, it may signify early hepatic damage, 
hypoxia, or mitochondrial injury in some instances (Nayak et al., 1996). It should be noted that liver 
dysfunction in HIV-infected individuals may be exacerbated by the presence of co-opportunistic 
infections including hepatitis A, B, C, D and E (Núñez, 2006). Therefore, the presence of severe 
histopathology would only occur in cases of severe toxicity. The liver is a highly regenerative organ 
able to adapt rapidly to cellular stressors and attenuate toxic bioproducts (Michanalopoulos, 2007). 
A study conducted by Nayak et al (1996) concluded that vacuolated hepatocytes are adapted to resist 
further damage.  
 
The presence of cellular changes in the C-R is negligible. As literature has shown the attenuating 
effects of rooibos against hydrogen peroxide (Ajuwon et al., 2013), carbon tetrachloride (Ulcina et 
al., 2008) and tert-butyl hydroperoxide (Canda et al., 2014) induced hepatotoxicity in rats, by 
reducing elevated AST and ALT liver enzymes. Arguably, these changes could be slightly injurious 
as rooibos has shown hepatotoxic effects in isolated instances of excessive intake (Sinsalo et al., 
2010, Engels et al., 2013, Zacharia &Whitlach, 2013). While Marnewick et al (2011) noted increased 
AST and ALT levels in individuals drinking six cups of rooibos daily, these levels were within 
physiologically relevant ranges. Additionally, Joubert et al (2005), cautioned against flavonoid rich 
fractions of fermented rooibos as these contained pro-oxidants that could, in turn, lead to pro-
oxidative stress. Studies reporting on ART induced hepatoxicity, have attributed these changes to 
alcohol abuse, direct liver injury, and the occurrence of co-morbid infections including hepatitis B 
and hepatitis C infections (Sulkowski et al., 2000; Wit et al., 2000; Carr, 2003; Dieterich et al., 2004;  
Núñez, 2006). While Mendes and Correia (2008) reason that liver damage exists in HIV patients, 
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independent of ART and that hepatic injury occurs in ART patients regardless of treatment. Thus, 
ART associated hepatoxicity is complex and should not be credited exclusively to its use.  
Tenofovir is eliminated by glomerular filtration and tubular secretions (Ray et al., 2006; Post et al., 
2010) implicating it in renal disease (Kohler et al., 2009; Lebrecht et al., 2009; Herlitz et al., 2010). 
Renal damage caused by TDF presents as proximal convoluted tubule (PCT) dysfunction (Post et al., 
2010), glomerular filtration rate changes (Fabien et al., 2013) or tubular ectasia with the loss of brush 
borders in PCT (Jao & Wyatt, 2010). Vrouenraets et al (2011) attributed glomerular filtration changes 
to tubular secretion and not to the actions of the glomerulus. Various diseases cause changes to the 
size, diameter, and width of the glomerular corpuscle and PCTs (Kotyk et al., 2016). 
Histopathological analysis of the kidney in the present study showed no pathological changes such 
as enlarged glomeruli, increased renal space area and width, or changes in the size of the glomerular 
corpuscle, indicative of nephrotoxicity. Preclinical studies using large doses of tenofovir, often ten to 
12 times larger than an average human dose (Hoesley, 2008) noted renal toxicities; yet, these changes 
were often reversible (Rӧling et al., 2006; Zimmerman et al., 2006; Hoesley, 2008).  
 
In rats, Lebrecht (2009) demonstrated that a dose of 100 mg/kg/day of tenofovir resulted in increased 
PCT diameter and concluded that the changes were associated with mitochondrial DNA depletions. 
The lack of significant changes in the PCT in the present study could be dose dependent as only 25.8 
mg/kg/day of TDF was administered, approximately four times less than that used by Lebrecht et al 
(2009). Although, the drugs administered in this study were combined, Mathias et al (2007) stated 
that the combination EFV/FTC/TDF actions were equivalent to their individual components. While 
histopathological analysis revealed the presence of vacuolations, these were so mild in the present 
study that the kidney was scored as normal. Although, vacuolation may signify the presence of early 
kidney damage, such as those seen with the use of the chemotherapy drug, cisplatin (Shea et al., 
2014). The lack of histological observable changes agrees with Kohler et al (2009), who observed no 
histological changes in the glomeruli and PCT using light microscopy in mice receiving a 100 
mg/kg/day dose of tenofovir. However, the same study found mitochondrial changes in the PCT 
lumen using electron microscopy, suggesting mitochondrial dysfunction as a possible cause for renal 
damage in patients receiving ART (Kohler et al., 2009). Mitochondrial toxicities with the use of TDF 
was further noted by Herlitz et al (2010). Furthermore, renal damage may depend on the patients 
profile (Kalyesubula & Perazella, 2011), such as having diabetes, kidney disease, using nephrotoxic 
drugs, or HIV-related pathologies (including HIVAN) (Kalyesubula & Perazella, 2011) that could 
exacerbate kidney injury. 
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To our knowledge this study is the first to morphometrically quantify the effects of rooibos on the 
histology of the kidney. Rooibos in this study did not cause any changes to the glomerular corpuscle 
or the PCT that could indicate damage. Rooibos is not expected to have a damaging effect on the 
kidney as it has shown attenuating effects in various other organs (Baba et al., 2009; Awoniyi et al., 
2011; Ajuwon et al., 2013). Limited research has been conducted on the effects of rooibos on the 
kidney; however, Opuwari & Monsees (2014) showed increased levels of creatinine with the use of 
fermented and unfermented rooibos tea solutions, suggesting changes in kidney function. However, 
no changes were observed histologically (Opuwari & Monsees, 2014; Monsees & Opuwari, 2017), 
agreeing with the lack of changes observed in the current study. 
 
Numerous health benefits have been reported with the use of rooibos (Ulcina et al., 2006; Joubert et 
al., 2008; Baba et al., 2009; Marnewick et al., 2009; Beltran-Debon et al., 2011; Joubert & de Beer, 
2011; Muller et al., 2016). Most of these studies attributed these changes to the actions of aspalathin, 
the rooibos plants most abundant polyphenol (Snijman et al., 2007, Snijman et al., 2009). Although 
aspalathin has shown potent antioxidant activity in vitro (von Gadow et al., 1997, Bramati et al., 
2003; Joubert et al., 2008; Krafczyk et al., 2009; Chen et al., 2013), in vivo studies using pure 
aspalathin have often lacked such positive results (Muller et al., 2016). Aspalathin ingested orally is 
not highly bioavailable and fails to follow Lipinski’s rule of five for the bioavailability of substances 
(Lipsinki et al., 2012), which points to its inability to cause significant changes in vivo (Muller et al., 
2016). In fact, aspalathin has shown to be metabolised by the intestine as C-glucosidases (Kreuz et 
al., 2008; Stalmach et al., 2009; Briter et al., 2011) and not in its original form. Recent research is 
moving towards evaluating the combined actions of rooibos polyphenols, as their synergistic action 
could increase the therapeutic potential of rooibos. For example, quercetin, nothofagin and orientin, 
well-known plant polyphenols, also found in rooibos have shown therapeutic effects in vivo (Eybl et 
al., 2008; Ku et al., 2015; Himpe et al., 2016). Thus, the therapeutic potential of rooibos polyphenols 
could be attributed to its multiple polyphenols each exerting its own effect (Snijman et al., 2007). 
Furthermore, fermented and unfermented extract versions are gaining prominence, as interests rise 
on the nutraceutical potential of rooibos (Joubert & de Beer, 2011). The lack of histological 
observable changes in the rooibos group, in the present study, could be accredited to the 
bioavailability of rooibos or the lack of a potent toxic drug to induce a change, that would allow the 
attenuating effects of rooibos to be observed. 
 
Rooibos polyphenols, specifically aspalathin, are prone to degradation when exposed to light, pH 
fluctuations and oxidation (Joubert, 1996; Standley et al., 2001). The current study investigated the 
effects of temperature and time on rooibos polyphenols in an aqueous solution, in an attempt to 
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elucidate whether the polyphenols would degrade before being administered to rats during 
experimentation. The main aim of this additional aspect of the study was to determine whether the 
rats in the current study would attain the same quantity of polyphenols throughout the week when 
kept in light limiting bottles. To our knowledge, no study has been conducted on the phenolic viability 
of the tea once fed to a rat cohort. Liquid chromatography-mass spectrometry was used to investigate 
the concentration and types of polyphenols found within the rooibos tea solutions. This is a high 
throughput method used to detect compounds in a solution such as serum and tea (Pitt, 2009). The 
present study did not find major difference between the fresh sample that was made up and the sample 
that remained for a week following the study protocol. The main polyphenols, aspalathin, its isomers, 
orientin and iso-orientin, quercetin-3-o-glucoside, apigenin-8-glucoside and nothofagin, were 
compared to the established quantified fermented samples conducted by Beelders et al (2012). No 
major changes in these polyphenols were observed between the control sample (Day 1 fresh) of the 
current study to those quantified by Beelders et al (2012). Although slight deviations were observed 
in Day 7 samples to the control, no major depreciation in these rooibos polyphenols were observed. 
Thus, we can adequately show that the animals used in the current study received similar quantities 
of polyphenols each week.  
 
To save research time, the study wanted to test if the phenolic concentrations would decrease if the 
samples were stored, as commercial iced tea versions of rooibos tended to have a lower antioxidant 
capacity (Joubert et al., 2009; de Beer et al., 2011). This is due to the fact that aspalathin is unstable 
in aqueous solutions. Although, studies have mentioned storing the tea at -20 °C (de Beer et al., 
2011), none to our knowledge have tested the tea once stored and given to rats in a research 
environment. The lack of drastic changes between refrigerated and frozen samples indicate that 
rooibos could be stored for up to a period of two weeks without a major compromise to the phenolic 
viability if light is limited and oxidation is prevented. The lack of change between groups could be 
attributed to the fact that light was limited and the tea was kept from being oxidised (de Beer et al., 
2011). Although aspalathin rich extract versions of rooibos are available and under investigation, 
aqueous solution such as the one used in this study are still used to test anecdotal evidence (Snijman 
et al., 2009), as fermented versions are still the most commonly consumed (South African Rooibos 
Council, 2011).  
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In conclusion, by suggesting that rooibos can attenuate the histological observable effects of ART is 
an overreach, if cART is not causing significant increases in oxidative stress, to warrant significant 
changes to organ histomorphology. No changes were observed at a histological level in any of the 
organs studied, that would indicate damage caused by ART or rooibos intake. There was a non-
significant increase in body weight with rooibos, thus, metabolic changes are unlikely. This was 
further reiterated by the lack of histological changes in the pancreas, liver, and kidney. Although, the 
liver demonstrated signs of potential damage, presenting as vacuolations, granular cytoplasmic 
changes, and in very rare instances, lymphocyte infiltration. These changes were very subtle and are 
often reversible (Michanalopoulos, 2007). These changes were additionally observed in the C-R 
group, which could indicate slight damage, as isolated reports have mentioned toxicity with chronic 
intake (Sinsalo et al., 2010, Engels et al., 2013, Zacharia & Whitlach, 2013). Additionally, this could 
be due to the pro-oxidant activities of rooibos (Joubert et al., 2005). Perhaps with a prolonged 
treatment period and increased dose, the histomorphological changes associated with ART would 
have been more overt. 
 
From the current study, we can deduce that the ADRs noted in the literature may be exacerbated by 
external variable such as the oxidative role of HIV, the occurrence of co-opportunistic infections, 
metabolic variations, or drug-drug interaction (Núñez, 2005; Meintjes et al., 2017). Furthermore, we 
can soundly state that a 2% rooibos tea solution and ART does not cause deleterious or attenuating 
effects to an extent that it would lead to individual and diverse changes to organ histomorphometry 
in rodents. Thus, answering the research questions, ART is not causing major histological changes 
over the period tested in this model. The co-administration of rooibos cannot be seen to attenuate 
ADRs as no major stressor occurred. This study upholds that ART, when given to rats for a nine week 
period does not cause overt histomorphological changes that would indicate damage, while the co-
administration of rooibos tea does not worsen or improve organ histomorphometry.  
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LIMITATIONS AND FUTURE STUDIES  
 
The inability to induce oxidative stress with ART limited the ability to observe any attenuating effects 
of rooibos. Analysis of TBARS was conducted on the same animals by another researcher, this 
oxidative measure is primarily used to test for lipid peroxidation. Future studies should focus on 
investigating total antioxidant capacity or measuring glutathione levels between groups as these 
would provide better indication of the oxidative stress or lack thereof.  
 
Tissue was shared with the Medical Physiology Department of Stellenbosch University in the effort 
to attain as much information as possible from animals in research. However, this limited the ability 
to obtain adequate amount of blood to conduct additional analyses, such as amylase in the pancreas 
or creatinine in the kidney. These tests would have provided an indication of pancreatic and kidney 
function, which could have validated the changes observed in these organs. As the animals were 
shared by many researchers the ability to retrieve samples at an optimum time may have led to 
autolysis which may further account for the slight pathological changes observed in these animals. 
Furthermore, the size of the sample and the fixation time may not have been sufficient. 
 
Keeping animals for longer period of times was not possible due to the incurred costs. Thus, the 
experimental period (9 weeks) may have been insufficient to allow for significant changes to be 
observed at a tissue level.  
 
Rooibos polyphenols are highly unstable in aqueous solutions, although, all efforts were ensured to 
maintain similar levels of polyphenols future studies could focus on using extract versions of the tea 
with an appropriate medium to be introduced to the animals. This will ensure that all animals received 
the same quantity of polyphenols daily. Future studies testing the therapeutic potential of rooibos 
could use unfermented rooibos leaves or extracts as these have increased concentrations of rooibos 
polyphenols. 
 
The study could have benefited from a longer experimental period, as this would have allowed for 
electron microscopic (EM) studies to be conducted. Mitochondrial toxicities have been described 
with the use of ART. Thus, analysis of the number, size, and shape of mitochondria at an EM level 
would provide an indication of mitochondrial toxicities and whether these changes could be averted 
with rooibos administration. 
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APPENDICES 
 
Appendix A: Outputs and awards arising from this study 
 
45th Annual Conference of the Anatomical Society of Southern Africa (ASSA), 23-26 April 2017, 
Langebaan, Western Cape: Pereira, D.L., Imperial, E., Webster, I., Strijdom, H., Widd, I., Chellan. 
N & Kotzé. S.H. 2017. The phenolic viability of rooibos teas (Aspalathus linearis) in research. 
 
Stellenbosch University, Department of Biomedical Sciences Annual Research day 23-
November 2016, Tygerberg, Cape Town: Pereira, D.L., Emperial, A., Webster, I., Wiid. I., Chellan, 
N & Kotzé, S.H. 2016. The viability of the antioxidant properties of rooibos tea under varying storage 
conditions. 
 
WhiteSci (Whitehead scientific) Best poster presentation 2016: Stellenbosch University, 
Department of Biomedical Sciences Annual Research day 23 November 2016, Tygerberg, Cape 
Town: Pereira, D.L., Emperial, A., Webster, I., Wiid. I., Chellan, N & Kotzé, S.H. 2016. The viability 
of the antioxidant properties of rooibos tea under varying storage conditions. 
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Appendix B: List of materials 
 
Table 1: List of materials 
Materials Company 
Odimune  Cipla Medpro (Pty) Ltd. Bellville. Western Cape 
Sodium Pentobarbitone  Eutha-naze©. Bayer (Pty). Ltd. Isando. Gauteng 
Standard breeders feed Nutritionhub (Pty) Ltd, Stellenbosch, South Africa 
Tools used for harvesting  
BD red vacationer 1 mL The Scientific Group (Pty) Ltd. (Milnerton, Western Cape, RSA) 
Blue top collection tubes - 
Gloves - 
Plastic Eppendorf tubes 1 mL - 
Scalpel  - 
Material for tea preparation 
Aluminium foil - 
Cheese cloth - 
Dried Rooibos leaves  Carmien tea company (Pty) Ltd Brakfonetin South Africa 
In virtis cryogenic flasks - 
Liquid Nitrogen - 
Protection gloves Avacare (Pty) Ltd Thailand 
Vacuum  Vacutec, Labconco Cat: 7753030 
Whatman No. 4 filter paper - 
Whatman No.1 filter paper - 
Material used for histology 
Cover slips (24 x 32 mm) - 
Cover slips (24 x 50 mm) - 
Double frosted glass microscope 
slides 
Kimix, Cat: 7107 
Embedding cassettes SPL Lifesciences (Pty) Ltd Cas: 400600 
Low profile microtome blades Leica microsystems (Pty) Ltd, Germany 
Paraffin wax (Embedding wax) Leica Microsystems (Pty) Ltd Cat: 39602012 
Plastic specimen jaws SPL Lifesciences(Pty) Ltd Cas: 400600 
Positively charged microscope 
slides 
Sigma-Aldrich (Pty) Ltd Cat no: S001 
Reagents used  
10% Formaldehyde SigmapAldrich (Pty) Ltd Cat: 47608 
5% Paraformaldehyde Sigma-Aldrich (Pty) Ltd Cat: P6148-1KG 
Acid Fuschin Sigma-Aldrich(Pty) Ltd 
AP Enzyme G/2 system AP 
Rabbit/mouse link (Enhancer) 
K5355, Dako, Denmark, Inc 
Dako Envision Kit K5355, Dako, Denmark, Inc 
Dako Liquid DAB +Chromogen K5355, Dako, North America, Inc 
DPX mounting media Associated Chemical Enterprises Batch: 30773 
Eosin Yellowish SAAR218600DC, Merck Chemicals (Pty) Ltd., Gauteng, South Africa 
Ethanol 99% Sigma-Aldrich Cas: 64-17-5 
Ferrous sulphate Sigma-Aldrich Cas: 127-03-55 
Glacial Acetic acid Sigma-Aldrich Cas: 10005706 
Hydrogen Peroxide  Merck (Pty) Ltd, Modderfontein, Gauteng 
Mayer’s Haematoxylin SAAR282201LC; Merck Chemicals (Pty), Ltd Gauteng 
Monoclonal Anti-insulin K5355, Dako, North America, Inc 
Normal Goat Serum - 
Normal Horse Serum - 
Orange G Sigma-Aldrich Cas: 1936-15-8  
Oxalic acid BDH Chemical Ltd Cat: 10174 
Phosphate Buffer solution Sigma-Aldrich Cas: P5358 
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Table 1: List of materials continued. 
Periodic acid Sigma-Aldrich Cas: P7875 
Permanent red chromogen 
substrate working solution 
K5355, Dako, Denmark, Inc 
Phosphotungstic acid Sigma-Aldrich Cas: P4006 
Polyclonal Anti-glucagon K5355, Dako, North America, Inc 
Ponceau de xylidine Sigma-Aldrich P2395 
Potassium permanganate BDH Chemicals, Cat: 10217 
Rabbit/mouse Link K5355, Dako, Denmark, Inc 
Schiff Reagent  Science World Batch: 08-01-127 
Silver nitrate Merch chemicals Pty, Ltd Cat: 576 50 40 DC 
Sodium hydroxide Sigma-Aldrich Cas:S 8045 
Strong ammonia (25%) Merck Chemicals, Pty Ltd Wadeville, Gauteng 
Sulfuric acid Sigma-Aldrich Cas: 339741 
Tris Buffer solution Sigma-Aldrich Cas: T5912 
Vector Laboratories ABC Kit VectorLaboratories Ak-5010 
Vector Laboratories Biotinylated 
Goat Anti-Rabbit IgG 
VectorLaboratories Ak-5010 
Xylene Sigma-Aldrich Cas: 214736 
Equipment used  
Biofuge Pico Centrifuge (Heraeus. Kendro Laboratory products. Germany 
Embedding table Leica EG 116 Embedder (SMM instruments. Johannesburg 
Incubator Model IH-150; Gallenkamp 
Leica Autostainer XL Leica ST 5010; Serial number 1732/02.2007 
Leica RM 2125 RT microtome Cat no. 045737989, SMM instruments, Gremnay  
Lobotec Vacuum Labcoco ™ (Vacutec. Roseveld park. South Africa 
Microscope camera (Nikon Digital Sight DS-Fic. Nikon corporation. Japan) 
Nikon Eclipse Ti Automated 
scanning microscope 
 (Nikon Instruments Inc. Walt Whitman Road Melville. New York)  
Oven  (Model: M53C. serial number 9513249 
Processor Shandon Elliot Duplex Processor OptoLaboratory. Cape Town 
Software used   
Leica Qwin professional 
software 
Leica Microsystems. United Kingdom 
Nikon NIS Imaging Software 
v4.40 
Nikon Instruments Inc. Copyright 1991-2015 
Statistica Version 13.2 Dell. 2014. USA 
Zen10 software Carl Zeiss Microscopy. Oberkochen 
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Appendix C: Odimune dose calculations (Imperial, 2017). 
 
Active ingredients 
 
Table 2: Active ingredients in one Odimune® tablet. 
Drug Active content Dose given to rats 
Efavirenz (EFV) 600 mg 51.0 mg/kg/day 
Emtricitabine (FTC) 200 mg 7.4 mg/kg/day 
Tenofovir (TDF) 300 mg 28.8 mg/kg/day 
 
Dose calculation for average 70 kg mature human 
Let EFV 600 mg= X 
Therefore. human dose (XH) in mg/kg/day= X/70 kg 
XH of Efavirenz = 600 mg/70 kg= 8.6 mg/kg/day 
XH of Emtricitabine= 200 mg/70 kg= 2.9 mg/kg/day 
XH of Tenofovir= 300 mg/70 kg= 4.3 mg/kg/day  
 
Human to rodent conversion 
Rodent dose (XR1) = XH * 6 
Therefore: 
XR1 of Efavirenz = 8.6 * 6= 51 mg/kg/ day 
XR1 of Emtricitabine= 2.9*6= 17.4 mg/kg/day 
XR1 of Tenofovir= 4.3* 6= 25.8 mg/kg/day 
 
Dosage calculation for average rat weighing 250g 
XR2 of Efavirenz= (XR1 * 0.250) = 12.9* 0.25= 12.9 
XR2 of Emtricitabine= 2.9*0.25= 4.35 mg 
XR2 of Tenofovir=25.8 mg* 0.25= 6.45 mg  
 
To determine the weight per tablet per rat 
Weigh the Tablet 
Take the human doe (X)/ specific dose of the rat (XR2) 
E.g. for Efavirenz: 600 mg dose/12.9 mg rat does= 46.51= Xr3 
Crush tablet with a pestle and mortar until a fine powder is formed 
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Therefore, the amount of crushed tablet to be dissolved per 1mL of water for Efavirenz= to the weight 
of the crushed Tablet/ Xr3. 
 
Preparation of the drug water mixtures 
For a four-day preparation of an entire cage. first determine the average weight of the rats per cage. 
Therefore. if the average body weight of the animals per cage after crushing is 352 g then the 352 g 
is first covert to kg therefore = 0.352 kg: 
Weight of the tablet after crushing= 1.6 g (1600 mg) 
Active ingredients (AI)= 600 mg+200 mg+300 mg=1100 mg 
Actual percentage of the AI= 1100/1600= 67.75% 
Average weight of the rats in cage= 352 (0.352 kg) 
Average weight of rats in cage= 352 g (0.352 kg) 
 
The dose per rat 
= EFV: 51.6 mg * 0.352mg =18.163 mg 
= EMT: 17.4 mg * 0.352 mg= 9.082 mg 
= EFV:600/18.16= (33*68%)/100= y 
=FTC: 200/6.125= (33*68%)/100= y 
=TDF: 300/9.082= (33*68%)/100= y 
Final dose of the tablet per rat: weight of the tablet (X)/Y 
EFV= 1600 mg/22.78=70.22 mg 
Powder of tablet in 1 mL water= 0.07 g 
For a 4-day preparation with 5 rats in a cage= 4*5 = 20 mL water 
Therefore. the final dose = 0.070* 20/= 1.40 g/20 mL water.  
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Appendix D: Blood transaminase methods (NHLS) 
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Appendix E: Tissue processing 
 
Protocol:  
1. Fix tissue in 5% paraformaldehyde for 48 hours.  
2. Add tissue to labelled cassettes with without litt. 
3. Process tissue in the tissue processor (Table 3). 
4. Once complete embed with paraffin wax and block. 
 
Table 3: Tissue processing steps 
Order Solution Time  Purpose 
1 5% Paraformaldehyde 12-24 h Fixation 
2 70% Ethanol 2.0 h Dehydration 
3 95% Ethanol 1.5 h Dehydration 
4 95% Ethanol 1.5 h Dehydration 
5 100% Ethanol 1.5 h Dehydration 
6 100% Ethanol 1.5 h Dehydration 
7 100% Ethanol 1.5 h Dehydration 
8 100% Xylene 1.5 h Clearing 
9 100% Xylene 1 h Clearing 
10 Paraffin (60 °C) 2 h Processing 
11 Paraffin (60 °C) 2 h Processing 
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Appendix F: Haematoxylin and eosin automatic staining protocol 
 
Protocol: 
1. Place deparaffinized slides into a plastic tissue rack. 
2. Place rack in the auto-stainer. 
3. Follow the programmed procedure listed in Table 4. 
 
Table 4: Haematoxylin and eosin staining protocol. 
Staining step Reagents Time  Repetition 
1 Xylene 10 min 2 
2 99% Ethanol 5 min 2 
3 96% Ethanol 2 min 1 
4 70% Ethanol 2 min 1 
5 Distilled water 5 sec 1 
6 Haematoxylin 8 min 1 
7 Running water 5 min 1 
8 Ethanol (1% acidic alcohol) 30 sec 1 
9 Running water 1 min 1 
10 0.2% Ammonia 45 sec 1 
11 Running water 5 min 2 
12 96% Ethanol 10 dips 1 
13 Eosin 45 sec 1 
14 96% Ethanol 5 min 2 
15 Xylene 5 min 2 
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Appendix G: Immunolabelling for anti-glucagon and anti-insulin 
 
As per the protocol from The Medical Research Council of South Africa (Diabetes Discovery 
Platform): SOP No: ICC\B7-V01. 
 
Table 5: Results of immunolabelling  
Cell Label 
α-cells Brown 
β-cells Red/pink 
 
Table 6: Reagents and quantities of immunolabelling kits. 
Reagents Quantity 
DAKO Polyclonal Anti-glucagon 
(rabbit) 1:100 
1 µl anti-glucagon + 99 µl 0.1M PBS = 100 µl/slide 
Vector Laboratories Biotinylated Goat 
Anti-Rabbit IgG 
11.25 µl made up to 2.5 mL 0.05 M TBS pH 7.2 
 
Vector Laboratories Vectastain ABC Kit 5 mL distilled water + 1 drop A and 1 drop B 
DAKO Liquid DAB+ Chromogen 1 mL substrate buffer + 1 drop DAB chromogen=100 
µL/slide/10x 
Sigma-Aldrich Monoclonal Anti-Insulin 
(mouse) 1:1 000 
5 µL 1:50 anti-insulin + 95 µL 0.1 M PBS = 100 µL/slide 
DAKO Envision Kit  
Rabbit/Mouse Link 100 µL/slide 
AP Enzyme (ENHANCER) 100 µL/slide 
Permanent Red Chromogen Substrate 
Working Solution 
10 µL permanent red chromogen + 1 000 µL permanent red 
substrate buffer = 100 µL/slide (10 slides) 
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Table 7: Immunolabelling protocol. 
Step Description Time 
1 Dewax sections through xylene and alcohol - 
2 Rinse slides in staining jar in distilled water - 
3 Block for endogenous peroxidase with 3% hydrogen peroxide (H2O2)  5 min 
4 Rinse slides with 0.05 M TBS pH 7.2 5 min 
5 Dry around the section  
6 Add 1:20 dilution of normal goat serum (NGS) to slides in a moisture chamber at room 
temperature (18 °C-20 °C) 
20 min 
7 Blot excess serum - 
8 Add 100 µL anti-glucagon primary antibody 1:100 to sections in moisture chamber and 
incubate at room temperature (18 °C-20 °C) 
30 min 
9 Jet wash with 0.05 M TBS pH 7.2 and rinse in staining jar in 0.05 M TBS pH 7.2  5 min 
9.1 Make up Biotinylated Anti-Rabbit igg and Vectastain)  - 
10 Dry around sections and add Biotinylated Anti-Rabbit IgG 1:200 to slides in moisture 
chamber at room temperature (18 °C-20°C)  
30 min 
11 Jet wash with 0.05 M TBS pH 7.2 and rinse in staining jar in 0.05M TBS pH 7.2 10 min 
12 Dry around sections and add Vectastain to slides in moisture chamber at room 
temperature (18 °C-20 °C) 
1 h 
13 Jet wash slides with 0.05 M TBS pH 7.2 and rinse in 0.05M TBS pH 7.2 in staining jar. 10 min 
14 Dry around sections and add Liquid DAB + Chromogen solution to slides on a rack over 
the sink  
5 min 
15 Jet wash slides with distilled water and rinse with distilled water in a staining jar 5 min  
16 Rinse slides in 0.05 M TBS pH 7.2 in staining jar 5 min 
17 Dry around section and add normal horse serum (NHS) 1:20 to slides in a moisture 
chamber minutes at room temperature (18 °C-20 °C). 
20 min 
18 Blot excess serum - 
19 Add 100 µL anti-insulin 1:10 000 to sections in moisture chamber and incubate 4 ºC Overnight 
20 Remove slides from the refrigerator and allow slides to reach room temperature - 
21 Jet wash with 0.05 M TBS pH 7.2 and rinse in staining jar in 0.05 M TBS pH 7.2 5 min 
22 Dry around sections and add 100 µL Rabbit/Mouse (LINK) to slides in moisture 
chamber room temperature (18 °C-20 °C) 
30 min 
23 Jet wash with 0.05 M TBS pH 7.2 and rinse in staining jar in 0.05 M TBS pH 7.2 10 min 
24 Dry around sections and add 100 µL AP Enzyme (ENHANCER) to slides in moisture 
chamber room temperature (18 °C-20 °C) 
30 min 
25 Jet wash slides with 0.05 M TBS pH 7.2 and rinse in 0.05 M TBS pH 7.2 in staining jar. 10 min 
26 Dry around sections and add Substrate Working Solution to slides on a rack at room 
temperature (18 °C-20 °C). Check progress under microscope 
3-5 min 
27 Jet wash slides with distilled water and rinse in distilled water in staining jar 5 min 
28 Counterstain with haematoxylin  2-4 min 
29 Rinse well in tap water - 
30 Leave to “blue” in tap water 30 min 
31 Dry completely on paper towel (section facing upwards) - 
32 Mount slides in DPX - 
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Appendix H: Gordan and Sweet staining protocol 
 
Table 8: Results of Gordan and Sweet’s silver impregnation. 
Structure Stain 
Reticulin fibres Black 
Nuclei Red 
 
Table: 9: Gordan and Sweet’s staining solutions. 
Stock solutions  Quantity 
Acidified Potassium permanganate XE   
0.5% Potassium permanganate  95 mL 
3% Sulphuric acid 5 mL  
Silver solution  
To 5 mL of 10% aqueous silver nitrate add strong ammonia drop by drop until the precipitate 
is just dissolved. Add 5 mL of 3% sodium hydroxide. Then add strong ammonia drop by 
drop until the resulting precipitate is almost completely dissolved. Make up to 50 mL using 
distilled water then pour into a clean coplin jar. NOTE: If too much ammonia is added there 
is a great loss of sensitivity 
 
2% aqueous oxalic acid  
Oxalic acid (analytical) 2 g  
Distilled water 100 mL 
Light green solution 0.1%  
Light green  0.1 g 
Acetic acid water 0.2%  100 mL  
4% aqueous iron alum  
Iron alum (Ferric ammonium sulphate) 4 g 
10% formalin  
Formaldehyde 40 g/L 10 mL  
Distilled water 90 mL 
Sodium thiosulphate (HYPO)  
Sodium thiosulphate 2 g 
Distilled water  100 mL 
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Figure 1: Bench work of the reticulin stain and photomicrograph of positive skin control. 
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Appendix I: Periodic acid schiff staining protocol 
 
Table 10: Period acid Schiff stain results. 
Structure Stain 
Glycogen. mucin and some basement membranes Red/purple 
Fungi Red/purple 
Background Blue  
 
Table 11: Periodic acid Schiff staining solutions. 
Stock solution Quantity 
0.5% Periodic acid solution  
Periodic acid  0.5 g 
Distilled water  100 mL 
Mayer’s Haematoxylin  Used as counterstain 
 
Test for Schiff Reagent.  
Pour 10 mL of 37% formalin into a watch glass. Using a pasteurized plastic pipette add a few drops 
of Schiff reagent to be tested. Usable Schiff will rapidly turn a red-purple colour. A deteriorating 
Schiff reagent will give a delayed reaction and the colour produced will be a deep blue-purple. 
 
s 
Figure 2: Periodic acid Schiff positive control. 
 
Table 12: Staining procedure for periodic acid Schiff. 
Step Procedure 
1 Deparaffinize and hydrate to water 
2 Oxidize in 0.5% periodic acid solution for 5 min 
3 Rinse in distilled water 
4 Place in Schiff reagent for 15 min (sections become a light pink colour in this step) 
5 Wash in luke warm water for 5 min (sections turn a dark pink colour in this step) 
6 Wash in running tap water for 5 min 
7 Dehydrate and mount using DPX mounting medium 
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Appendix J: Masson's trichrome staining protocol 
 
Table 13: Results of Masons trichrome stain. 
Structure Stain 
Nuclei Black 
Cytoplasm Red 
Mucin Green 
Erythrocytes Yellow/Orange 
 
Table 14: Masson’s Trichrome staining solutions. 
Stock solutions  Quantity 
Haematoxylin Counterstain 
Acetic acid water  
Glacial acetic acid  2 mL 
Distilled water  100 mL 
Masson Fuchson Ponceau-Orange G: Stock solution  
Ponceau de xylidine (Ponceau 2R) 2 g 
Acid Fuchson  1 g 
Orange G  2 g 
Acetic Acid water 0.2%  300 mL 
Masson Fuchson Ponceau-Orange G: Working solution  
No. 3 (MFPOG)  0.1 g 
Acetic acid water 0.2%  100 mL 
Light green solution 0.1%  
Light green  0.1g 
Acetic acid water 0.2%  100 mL 
5% Phosphotungstic acid  
Phosphotungstic acid  5 g 
Distilled water  100 mL 
 
Table 15: Masson’s trichrome staining procedure 
Step Procedure 
1 Deparaffinize sections as usual, wash in tap water, place in Distilled water 
2 Stain in Haematoxylin for 5 min. Place in tap water for 3 min until dark blue 
3 Rinse in distilled water 
4 Stain the sections in filtered working solution of Fuschin ponceau-orange G for 20 min 
5 Rinse in acetic acid water 
6 Mordont in 5% Phosphotungstic acid solution for 5 min 
7 Rinse in acetic acid water for 1 min 
8 Stain in light green solution for 20 mi 
9 Treat with acetic acid water for 5 min 
10 Dehydrate as usual 
11 Mount in DPX 
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Appendix K: Randomisation techniques for the kidney 
 
 
Figure 3: Randomisation of the kidney images to be measured. A) Images in a folder for the specific slide 
were captured and added to a Microsoft computer folder. B) All images containing one or more glomerular 
corpuscle (GLOM) were selected and placed in a secondary file “B”. C) From file “B” every 5th image was 
selected and placed in a third file “C”. D) File “C” was labelled with the slide number and a letter M indicating 
that it was the measurement file. 
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Appendix L: Freeze drying techniques 
 
Table 16: Freeze drying procedures.  
Step Procedure 
1 Make up 2% tea solution using 20 g tea leaves to 100 mL water 
2 Filter the tea using the Whatman No.1 and No.4 filter paper 
3 Follow the experimental procedure of storage 
4 Place tea in virtis cryogenic flasks 
5 Place tea in liquid nitrogen constantly turning to “shell “the tea  
6 Once frozen add tea to the vacuum until completely powdered (3-4 days)  
7 Collect tea and place in blue top labelled collection jars wrapped in aluminium foil  
8 Place freeze dried material in a dark dry cupboard until analysis 
 
 
Figure 4: Tea preparation for freeze drying. A) Tea is placed in virtis cryogenic flask. B) Tea is placed in 
liquid nitrogen for shelling. C) Tea is added to the vacuum for freeze drying. 
 
 
Figure 5: Final tea product in powdered form. 
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Appendix M: Supplementary data 
 
Body weight 
 
Figure 6: Body mass and Post hoc values of the various treatment groups. Control (C); Control 
antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
 
Table 17: Post hoc tests for body weight.  
Body weight  
 C C-ART C-R ART+R 
C - 0.575514 0.032027 0.611053 
C-ART 0.575514 - 0.104484 0.958778 
C-R 0.032027 0.104484 - 0.094463 
ART+R  0.611053 0.958778 0.094463 - 
Red values indicate trends between groups. Control (C); Control antiretroviral therapy (C-ART); Control 
rooibos (C-R), Experimental (ART+R).
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Supplementary data of the pancreas 
  
Table 18: Pancreas tissue, islet and α-and β-cell areas.  
 Control  Control ART Control 
rooibos  
Experimental  ANOVA  
Total tissue area 56769450.20 
±15418089.17 
42010002.95± 
13680705.74 
48832091.96± 
22742602.63 
1824331.12± 
14726164.83 
P= 0.18 
Total islet area 531643.48± 
196382.79 
42010002.95± 
13680705.74 
390043.82± 
242175.09 
392958.05± 
216995.24 
P= 0.21 
Mean total tissue area 284625.55± 
35291.64 
296050.94± 
63474.00 
269161.83± 
31287.63 
291683.93± 
66141.82 
P= 0.67 
Mean islet area 6687.41± 
1814.76 
8490.46± 
1913.10 
7045.13± 
1849.34 
7642.43± 
3833.00 
P= 0.41 
Total α-cell area 58386.29± 
21707.81 
38968.23± 
18220.07 
45311.38± 
26933.84 
38654.43± 
21894.71 
P= 0.19 
Total β-cell area 325057.13± 
114828.43 
200088.85± 
98123.16 
218006.68± 
130203.86 
250194.25± 
122158.03 
P= 0.10 
Mean α-cell area 750.19± 
277.73 
1004.76± 
359.70 
853.38± 
187.04 
781.28± 
513.30 
P= 0.40 
Mean β-cell area 4066.03± 
1049.48 
5134.54± 
1202.88 
4046.94± 
1176.65 
5124.45± 
2996.43 
P= 0.33 
Mean islet to mean 
tissue area 
0.410983± 
0.256026 
0.311348± 
0.206240 
0.332261± 
0.188032 
0.395518± 
0.188435 
P= 0.67 
 
Percentage β-cells 61.19120± 
4.157628 
 
60.62224± 
4.705751 
 
57.22070± 
3.761853 
 
65.51155± 
7.315311 
 
P= 0.01 
Percentage α-cells 11.01506± 
2.248966 
11.73030± 
2.967841 
12.78256± 
4.051737 
9.82752± 
1.681862 
P= 0.15 
Red values indicate significant difference p< 0.05. Control (C); Control antiretroviral therapy (C-ART); 
Control rooibos (C-R), Experimental (ART+R).
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Table 19: Post hoc tests for the pancreas. 
Pancreas section areas 
 C C-ART C-R ART+R 
C - 0.060387 0.304043 0.057376 
C-ART 0.060387 - 0.376108 0.980676 
C-R 0.304043 0.376108 - 0.363400 
ART+R 0.057376 0.980676 0.363400 - 
Mean pancreas section areas 
C - 0.623167 0.506621 0.761223 
C-ART 0.623167 - 0.251105 0.850812 
C-R 0.506621 0.251105 - 0.335088 
ART+R 0.761223 0.850812 0.335088 - 
Total number of islets 
C - 0.006118 0.101526 0.217657 
C-ART 0.006118 - 0.225811 0.105997 
C-R 0.101526 0.225811 - 0.672849 
ART+R 0.217657 0.105997 0.672849 - 
Total α-cell area 
C - 0.060506 0.200213 0.056658 
C-ART 0.060506 - 0.530703 0.975190 
C-R 0.200213 0.530703 - 0.510690 
ART+R 0.056658 0.975190 0.510690 - 
Total β-cell area 
C - 0.022216 0.047994 0.160876 
C-ART 0.022216 - 0.733855 0.344362 
C-R 0.047994 0.733855 - 0.542075 
ART+R 0.160876 0.344362 0.542075 - 
Total islet area 
C - 0.044541 0.138281 0.146331 
C-ART 0.044541 - 0.575037 0.554243 
C-R 0.138281 0.575037 - 0.975284 
ART+R 0.146331 0.554243 0.975284 - 
Mean islet area 
C - 0.117878 0.520199 0.845949 
C-ART 0.117878 - 0.347108 0.168184 
C-R 0.520199 0.347108 - 0.652761 
ART+R 0.845949 0.168184 0.652761 - 
Mean β-cell area 
C - 0.191930 0.981178 0.196059 
C-ART 0.191930 - 0.184298 0.990055 
C-R 0.981178 0.184298 - 0.188301 
ART+R 0.196059 0.990055 0.188301 - 
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Table 19: Post hoc tests for the pancreas continued. 
Mean α-cell area 
C - 0.117878 0.520199 0.845949 
C-ART 0.117878 - 0.347108 0.168184 
C-R 0.520199 0.347108 - 0.652761 
ART+R 0.845949 0.168184 0.652761 - 
Percentage of α-cells 
C - 0.581730 0.178032 0.362181 
C-ART 0.581730 - 0.418846 0.147884 
C-R 0.178032 0.418846 - 0.027565 
ART+R 0.362181 0.147884 0.027565 - 
Percentage of β-cells 
C - 0.807178 0.094789 0.070059 
C-ART 0.807178 - 0.150259 0.041610 
C-R 0.094789 0.150259 - 0.000998 
ART+R 0.070059 0.041610 0.000998 - 
Mean number of islets per section area 
C - 0.299208 0.410761 0.871045 
C-ART 0.299208 - 0.826270 0.379460 
C-R 0.410761 0.826270 - 0.507922 
ART+R 0.871045 0.379460 0.507922 - 
Red values indicate trends between group. Control (C); Control antiretroviral therapy (C-ART); Control 
rooibos (C-R), Experimental (ART+R).
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Supplementary data of the liver 
 
Table 20: Descriptive statistics and standard deviations (±) of serum analysis. 
 C C-ART C-R ART+R ANOVA 
ALT 62.40±36.44 54.40±30.55 60.30±30.29 56.40±68.11 P= 0.98 
AST 181.50±107.14 160.80±75.50 170.80±109.94 143.50±141.08 P= 0.89 
AST: ALT 2.92±0.60 3.02±0.70 2.94±1.10 2.78±0.59 P= 0.92 
Haemoglobin 50.90±27.91 98.00±69.80 49.60±25.60 52.60±24.1 P= 0.04 
Lipaemia 12.00±12.70 8.25±2.38 9.40±4.27 12.70±13.83 P= 0.63 
Red values indicate significant difference p<0.05. Control (C); Control antiretroviral therapy (C-ART); 
Control rooibos (C-R), Experimental (ART+R). 
 
Table 21: Post hoc tests of serum tests. 
Serum ALT  
 C C-ART C-R ART+R 
C - 0.844722 0.767083 0.915994 
C-ART 0.844722 - 0.919980 0.763257 
C-R 0.767083 0.919980 - 0.688118 
ART+R  0.915994 0.763257 0.688118 - 
Serum AST 
C - 0.585310 0.841299 0.830360 
C-ART 0.585310 - 0.729187 0.448435 
C-R 0.841299 0.729187 - 0.678802 
ART+R  0.830360 0.448435 0.678802 - 
Serum lipaemia 
C - 0.385565 0.774485 0.493292 
C-ART 0.385565 - 0.271596 0.853194 
C-R 0.774485 0.271596 - 0.352964 
ART+R  0.493292 0.853194 0.352964 - 
Serum AST: ALT  
C - 0.644110 0.821639 0.963499 
C-ART 0.644110 - 0.492777 0.677130 
C-R 0.821639 0.492777 - 0.786282 
ART+R  0.963499 0.677130 0.786282 - 
Serum haemoglobin 
C - 0.865161 0.013612 0.941331 
C-ART 0.865161 - 0.019997 0.923331 
C-R 0.013612 0.019997 - 0.016105 
ART+R  0.941331 0.923331 0.016105 - 
Red values indicate trends between groups. Control (C); Control antiretroviral therapy (C-ART); Control 
rooibos (C-R), Experimental (ART+R). 
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Supplementary data of the kidney 
 
Table 22: Descriptive statistics and standard deviations (±) of kidney measurements. 
 C C-ART C-R ART+R  
Corpuscle 
area  
7483.33± 502.72 
 
7662.31±1275.82 
 
8147.81±1067.56 
 
6954.41±1249.32 P= 0.11 
Corpuscle 
perimeter 
316.82± 10.85 
 
319.84±26.93 
 
329.51±21.69 
 
304.37± 26.84 P= 0.12 
Corpuscle 
diameter 
96.48±3.24 97.59±8.07 100.55±6.48 
 
93.37±9.04 P= 0.17 
Glomerular 
area 
4975.91±336.15 
 
4915.14±741.04 
 
5384.6±855.79 
 
4741.51±866.02 P= 0.26 
Glomerular 
perimeter 
297.52±15.10 
 
313.26±36.84 
 
315.68±32.46 283.40±37.67 
 
P= 0.10 
Glomerular 
diameter 
78.28±2.96 77.69±5.90 81.30 ± 6.17 76.64± 7.87 
 
P= 0.36 
Renal space 
area 
2507.42± 284.83 
 
2747.18±637.98 2763.14± 
680.75 
2212.90± 
473.95 
P= 0.10 
Renal space 
width  
18.20±1.89 19.90±3.49 19.25±4.51 16.73±2.56 P= 0.16 
Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
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Table 23: Post hoc tests of glomerular corpuscle and glomerulus. 
Corpuscle area  
 C C-ART C-R ART+R 
C - 0.710612 0.173544 0.276418 
C-ART 0.710612 - 0.317148 0.147798 
C-R 0.173544 0.317148 - 0.017379 
ART+R  0.276418 0.147798 0.017379 - 
Corpuscle perimeter  
C - 0.766384 0.216340 0.224647 
C-ART 0.766384 - 0.343928 0.133560 
C-R 0.216340 0.343928 - 0.017365 
ART+R  0.224647 0.133560 0.017365 - 
Corpuscle diameter 
C - 0.727530 0.205028 0.331016 
C-ART 0.727530 - 0.353695 0.189767 
C-R 0.205028 0.353695 - 0.028890 
ART+R  0.331016 0.189767 0.028890 - 
Glomerular area 
C - 0.853797 0.219981 0.478707 
C-ART 0.853797 - 0.160231 0.599203 
C-R 0.219981 0.160231 - 0.057272 
ART+R  0.478707 0.599203 0.057272 - 
Glomerular perimeter 
C - 0.276488 0.210514 0.328190 
C-ART 0.276488 - 0.866050 0.043153 
C-R 0.210514 0.866050 - 0.029554 
ART+R  0.328190 0.043153 0.029554 - 
Glomerular diameter 
C - 0.826950 0.266965 0.544781 
C-ART 0.826950 - 0.186152 0.697969 
C-R 0.266965 0.186152 - 0.090589 
ART+R  0.544781 0.697969 0.090589 - 
Renal space area 
C - 0.329425 0.298692 0.232478 
C-ART 0.329425 - 0.947897 0.034071 
C-R 0.298692 0.947897 - 0.029365 
ART+R  0.232478 0.034071 0.029365 - 
Renal space width  
C - 0.329425 0.298692 0.232478 
C-ART 0.329425 - 0.947897 0.034071 
C-R 0.298692 0.947897 - 0.029365 
ART+R  0.232478 0.034071 0.029365  
Red values indicate trends between groups. Control (C); Control antiretroviral therapy (C-ART); Control 
rooibos (C-R), Experimental (ART+R). 
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Table 24: Post hoc tests of the proximal convoluted tubules.  
Outer surface area 
 C C-ART C-R ART+R 
C - 0.792179 0.316467 0.620982 
C-ART 0.792179 - 0.457873 0.449723 
C-R 0.316467 0.457873 - 0.138596 
ART+R  0.620982 0.449723 0.138596 - 
Outer surface perimeter 
C - 0.753112 0.271227 0.694184 
C-ART 0.753112 - 0.428704 0.480256 
C-R 0.271227 0.428704 - 0.138820 
ART+R  0.694184 0.480256 0.138820 - 
Outer surface diameter 
C - 0.816939 0.370979 0.815334 
C-ART 0.816939 - 0.505383 0.642286 
C-R 0.370979 0.505383 - 0.261309 
ART+R  0.815334 0.642286 0.261309 - 
Luminal surface area 
C - 0.942646 0.072681 0.268109 
C-ART 0.942646 - 0.084091 0.239026 
C-R 0.072681 0.084091 - 0.005222 
ART+R  0.268109 0.239026 0.005222 - 
Luminal perimeter 
C - 0.941045 0.115218 0.338141 
C-ART 0.941045 - 0.132374 0.302879 
C-R 0.115218 0.132374 - 0.013938 
ART+R  0.338141 0.302879 0.013938 - 
Luminal diameter 
C - 0.971471 0.084018 0.317194 
C-ART 0.971471 - 0.090226 0.300560 
C-R 0.084018 0.090226 - 0.008347 
ART+R  0.317194 0.300560 0.008347 - 
PCT wall area  
C - 0.733730 0.850852 0.950892 
C-ART 0.733730 - 0.878917 0.780472 
C-R 0.850852 0.878917 - 0.899356 
ART+R  0.950892 0.780472 0.899356 - 
PCT wall diameter  
C - 0.746867 0.257475 0.272601 
C-ART 0.746867 - 0.148670 0.435345 
C-R 0.257475 0.148670 - 0.029645 
ART+R  0.272601 0.435345 0.029645 - 
Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
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Figure 7: Bar graphs showing the size of the PCTs. Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
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Figure 8: Single rooibos chromatograms of Day 1 samples, with retention times and molecular weights of the compounds. Day 1 (D1). 
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` 
Figure 9: Single rooibos chromatograms of Day 7 samples, with retention times and molecular weights of the compounds. Day 7 (D7).
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Table 25: Pathology overview: Pancreas. 
 Animal number 
 
Granular  
changes 
Vacuolation 
 
Lymph infiltration 
 
Description  
 
 C1 0 0 0 normal 
C
o
n
tr
o
l 
C2 0 0 0 normal 
C3 0 0 0 normal 
C4 0 0 0 normal 
C5 0 0 0 normal 
C6 0 0 0 normal 
C7 0 0 0 normal 
C8 0 0 0 normal 
C9 0 0 0 normal 
C10 0 0 0 normal 
C
o
n
tr
o
l 
A
R
T
 
C-ART1 0 0 0 normal 
C-ART2 0 0 0 normal 
C-ART3 0 0 0 normal 
C-ART4 0 0 0 normal, lymph node shows mild activity 
C-ART5 0 0 0 normal, lymph node with active centre 
C-ART6 0 0 0 normal 
C-ART7 0 0 0 normal 
C-ART8 0 0 0 normal, mild activity at the lymph node 
C-ART9 0 0 0 normal 
C-ART10 0 0 0 normal, mild lymph activity at the lymph node 
C
o
n
tr
o
l 
ro
o
ib
o
s 
C-R1 0 0 0 normal 
C-R2 0 0 0 normal 
C-R3 0 0 0 normal 
C-R4 0 0 0 normal, lymph node with active centre 
C-R5 0 0 0 normal 
C-R6 0 0 0 normal, lymph node with active centre 
C-R7 0 0 0 normal, lymph node with active centre 
C-R8 0 0 0 normal 
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Table 25: Pathology overview: Pancreas continued. 
C-R9 0 0 0 normal 
C-R10 0 0 0 normal 
E
x
p
er
im
en
ta
l 
ART+R1 0 0 0 normal 
ART+R2 0 0 0 normal, lymph node with active centre 
ART+R3 0 0 0 normal, lymph node with active centre 
ART+R4 0 0 0 normal, lymph node with active centre 
ART+R5 0 0 0 normal 
ART+R6 0 0 0 normal 
ART+R7 0 0 0 normal 
ART+R8 0 0 0 normal 
ART+R9 0 0 0 normal 
ART+R10 0 0 0 normal, lymph node shows mild activity 
Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R).  
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Table 26: Pathology overview: Liver. 
 
Animal  
number 
Granular 
cytoplasm 
Vacuolation 
 
Lymph 
infiltration 
 
Description 
 
C
o
n
tr
o
l 
C1 1 1 0 
Slight vacuolisation present diffuse, granular cytoplasm observed, minimal disruption of reticulin 
towards capsule 
C2 0 0 0 Normal 
C3 0 0 1 Very slight lymph infiltration otherwise normal only localised at one portal tract 
C4 0 0 0 Normal 
C5 1 1 1 Vacuolisation around central veins, granular appearance mostly diffuse, lymph infiltration 
C6 0 0 0 Normal 
C7 1 0 0 Slight granular appearance of the cytoplasm mostly diffuse 
C8 0 1 0 Slight vacuolation present diffuse, slight disruption of RT at vacuolated areas and towards capsule 
C9 0 1 0 Slight vacuolisation evident at the central veins 
C10 0 1 0 
Vacuolation around portal tracts and central vein, RT disruption in vacuolated areas and towards 
capsule 
C
o
n
tr
o
l 
A
R
T
 
C-ART1 1 1 1 
Granular cytoplasm, vacuolisation around central veins, inflammatory cells diffuse RT, disruption 
around vacuolated areas 
C-ART2 0 1 1 Slight inflammatory foci present, slight vacuolisation is observed, RT disruption to wards capsule 
C-ART3 1 1 0 
Slight vacuolisation and granular appearance of the cytoplasm around central veins, RT disruption 
towards capsule and around vacuolated areas  
C-ART4 1 1 0 
 vacuolisation and granular cytoplasmic appearances around portal areas and central veins, 
Disruption  
C-ART5 1 1 0 Granular cytoplasm slight vacuolation present  
C-ART6 0 1 1 
Slight vacuolisation seen around the portal regions, slight lymphocyte infiltration slight disruption 
of RT and vacuolated areas 
C-ART7 0 0 0 Normal 
C-ART8 0 0 0 Normal 
C-ART9 0 1 0 Slight vacuolation mostly diffuse, RT disrupted at vacuolated areas and at the capsule 
C-ART10 1 1 0 Vacuolisation and, slight granular cytoplasm is visible. Liver looks slightly hyperaemic 
C
o
n
tr
o
l 
ro
o
i
b
o
s C-R1 0 0 0 Normal  
C-R2 0 0 0 Normal 
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Table 26: Pathology overview: Liver continued. 
C-R3 1 1 0 
Slight vacuolisation mostly diffuse granular cytoplasm observed, RT slight disruption in vacuolated 
areas 
C-R4 0 1 0 Slight granular cytoplasm 
C-R5 1 1 0 Slight vacuolisation, granular cytoplasm mostly diffuse, RT slight disruption in vacuolated areas 
C-R6 0 1 0 Slight vacuolisation present RT slight disruption in vacuolated areas 
C-R7 1 0 0 Granulated cytoplasm with slight vacuolisation diffuse 
C-R8 1 0 0 Granular cytoplasm mostly diffuse 
C-R9 1 0 0 
Slight vacuolisation around the central veins, RT slight disruption in vacuolated areas and towards 
the capsule 
C-R10 1 1 0 
Slight vacuolisation around portal areas and central vein, slight granular cytoplasm, RT slight 
disruption in vacuolated areas 
E
x
p
er
im
en
ta
l 
ART+R 1 0 0 0 
Normal, see slight bridging confirm with MT. No bridging found on trichrome, RT slight disruption 
in vacuolated areas and around portal areas 
ART+R 2 1 0 0 Slight granular appearance of the cytoplasm mostly diffuse 
ART+R 3 0 1 0 Slight vacuolisation, RT slight disruption in vacuolated areas 
ART+R 4 0 1 0 Slight vacuolisation, RT slight disruption in vacuolated areas 
ART+R 5 1 1 0 
Slight vacuolisation around portal areas and granulated cytoplasm, RT slight disruption in 
vacuolated areas 
ART+R 6 0 1 0 Slight vacuolisation around portal regions, RT slight disruption in vacuolated areas 
ART+R 7 0 0 0 Normal 
ART+R 8 1 1 0 
Slight vacuolisation around portal areas and granulated cytoplasm, RT slight disruption in 
vacuolated areas 
ART+R 9 0 1 0 
Slight vacuolisation around portal regions, slight granular appearance mostly diffuse, RT slight 
disruption in vacuolated areas and towards the capsule could be artefactual 
ART+R 
10 1 1 0 
Slight vacuolisation around portal areas and granulated cytoplasm. RT slight disruption in 
vacuolated areas 
Reticulin fibres (RT); Masson’s Trichrome (MT). Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
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Table 27: Pathology overview: Kidney. 
 Animal 
number  
Granular  
cytoplasm 
Vacuolation 
 
Lymph infiltration 
 
Description 
 
C
o
n
tr
o
l 
C1 0 0 0 Normal, slight congestion slight autolysis 
C2 0 0 0 Normal, random vacuolation 
C3 0 0 0 Protein casts present 
C4 0 0 0 Vacuolation is present but negligible and some proteinaceous material 
C5 0 0 0 Normal 
C6 0 0 0 Proteinaceous material present, random vacuolation 
C7 0 0 0 Normal 
C8 0 0 0 Normal 
C9 0 0 0 Slight basophilic (artefactual), slight congestion 
C10 0 0 0 Slight basophilic (artefactual), slight congestion 
C
o
n
tr
o
l 
A
R
T
 
C-ART1 0 0 0 Random vacuolation (could be due to autolysis) 
C-ART2 0 0 0 Random vacuolation 
C-ART3 0 0 0 Protein casts, slight congestion 
C-ART4 0 0 0 Protein casts present, with what appears to be vacuolation (autolysis) 
C-ART5 0 0 0 Mild autolysis  
C-ART6 0 0 0 Slight protein casts 
C-ART7 0 0 0 Random vacuolation (artefactual) 
C-ART8 0 0 0 Looks slight basophilic (artefactual), slight congestion 
C-ART9 0 0 0 Looks slightly congested  
C-ART10 0 0 0 Normal, slightly congestion, random vacuolation 
C
o
n
tr
o
l 
ro
o
ib
o
s 
C-R1 0 0 0 Normal 
C-R2 0 0 0 Normal 
C-R3 0 0 0 Normal 
C-R4 0 0 0 Proteinaceous material/ casts present 
C-R5 0 0 0 Proteinaceous material present, vacuolation present but negligible 
C-R6 0 0 0 Proteinaceous material was found 
C-R7 0 0 0 Proteinaceous material was found 
C-R8 0 0 0 Protein casts present, random slight vacuolation 
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Table 27: Pathology overview: Kidney continued. 
C-R9 0 0 0 Slight artefactual, random vacuolation in DCT  
E
x
p
er
im
en
ta
l 
C-R10 0 0 0 Looks slightly congested, random vacuolation 
ART+R1 0 0 0 Normal 
ART+R2 0 0 0 Normal 
ART+R3 0 0 0 Normal 
ART+R4 0 0 0 Proteinaceous material was present, red blood cells look slightly engorged 
ART+R5 0 0 0 Mild autolysis 
ART+R6 0 0 0 Engorged red blood cell, autolysis could be misinterpreted as hydropic change 
ART+R7 0 0 0 Protein casts present, random vacuolation in medullary region 
ART+R8 0 0 0 Normal 
ART+R9 0 0 0 Protein casts 
ART+R10 0 0 0 Some protein casts 
Control (C); Control antiretroviral therapy (C-ART); Control rooibos (C-R), Experimental (ART+R). 
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